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Abstract 
Invasive fungal diseases (IFDs) are a major course of morbidity and mortality world-
wide and new antifungals are urgently needed. IFDs caused by the human fungal pathogen 
Cryptococcus neoformans result in >625,000 deaths from meningoencephalitis annually in 
HIV-infected patients alone. C. neoformans is also a well-accepted fungal model used for 
studying pathogenesis mechanisms. It produces a range of virulence factors to enable it to 
cause disease, including a polysaccharide capsule and melanin. Extracellular 
acid phosphatase activity has been detected in over 95% of the C. neoformans strains 
isolated from patients with AIDS, including the highly-virulent serotype A reference strain 
H99. Acid phosphatase activity is produced by numerous microbes when free phosphate (Pi) 
is limited to release Pi from complex organic sources. However the contribution of this 
activity to the virulence of C. neoformans has never been determined.  
As part of this study, a BLAST search of the C. neoformans H99 genome was 
performed using the secreted, Pi-repressible acid phosphatase, Pho5, from Saccharomyces 
cerevisiae as a query, and four uncharacterised acid phosphatases were identified: CNAG 
02944 (Aph1), CNAG_06967 (Aph2), CNAG_02681 (Aph3) and CNAG_06115 (Aph4). Only 
Aph1 is predicted to be secreted. By creating an isogenic APH1 gene deletion mutant strain 
(∆aph1) from H99 and comparing the two strains, the aims of this study were to determine 
(1) whether Aph1 is the secreted acid phosphatase responsible for the extracellular acid 
phosphatase activity in H99, and APH1 responsiveness to Pi, (2) Aph1 substrate specificity (3) 
the role of Aph1 in fungal cellular function and virulence and  (4) whether APH2, APH3 and 
APH4 are also Pi-responsive genes and whether their expression profile is altered in the 
absence of APH1. APH1 gene deletion in ∆aph1 transformants was confirmed by the 
acquisition of neomycin resistance (since APH1 coding sequence was replaced with a 
neomycin resistance gene (NEOR)), by PCR amplification across the recombination junctions 
of the APH1 deletion construct, and by the absence of extracellular acid phosphatase 
activity, as assessed using the chromogenic substrate para-nitrophenyl phosphate (pNPP).  
To examine whether Aph1 production correlated with Pi availability, WT and ∆aph1 
were incubated in the presence and absence of Pi and their secretions were assayed 
spectrophotometrically for acid phosphatase activity over an 80 min time course using pNPP. 
In contrast to WT, which produced acid phosphatase activity in the absence of phosphate, 
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∆aph1 produced almost no detectable extracellular acid phosphatase activity. This finding 
indicates that APH1 gene product contributes all of the extracellular acid phosphatase 
activity in C. neoformans, and production of Aph1 is induced by Pi deprivation. Pi 
deprivation also induced APH1 gene expression in WT, but not in ∆aph1, as measured by 
qPCR. The ability of WT and ∆aph1 secretions to hydrolyse a broad range of phosphorylated 
substrates was compared using a malachite green assay. Phosphotyrosine (but not 
phosphoserine and phosphothreonine), glucose-1-phosphate, β-glycerol phosphate, 
adenosine monophosphate (AMP) and mannose-6-phosphate were all found to be 
substrates of Aph1. The absence of APH1 in Δaph1 did not compromise the growth of C. 
neoformans under normal and stress conditions, including human physiological temperature 
(37°C), its ability to produce melanin and capsule or its ability to grow in the absence of an 
external source of phosphate. However, Δaph1 was less virulent in the Galleria mellonella 
(wax moth) and mouse inhalation models of cryptococcosis. The mechanism for the reduced 
virulence was unlikely to be due to a role for Aph1 in facilitating adhesion of C. neoformans 
to lung epithelium as indicated in previous studies by others, since WT and Δaph1 bound to 
a lung epithelial cell line, A549, to a similar extent.  
Expression of APH2, APH3 and APH4, encoding intracellular acid phosphatases, was 
also investigated. Similar to APH1, APH3 and APH4, and to a lesser extent APH2, were 
induced during Pi-deprivation in WT. To test the possibility that the intracellular acid 
phosphatases compensate for the lack of Aph1 in the Δaph1 mutant, the expression of 
these genes in ∆aph1 under inducing (Pi-deficient) conditions was quantified. However, the 
expression of APH2-APH4 in Δaph1 was not higher than in WT, indicating that any potential 
compensation by APH3 and APH4 in the absence of APH1 is not reflected at the 
transcriptional level.  
In conclusion, Aph1 is the major secreted acid phosphatase in C. neoformans and 
similar to Pho5 from S. cerevisae, Aph1 production is regulated at the transcriptional level in 
response to Pi-availability. Similarly, expression of the other acid phosphatases, especially 
Aph3 and Aph4, is regulated by Pi availability, indicating that they are also components of 
the phosphate-responsive (PHO) system in C. neoformans. Aph1 contributes to the virulence 
of C. neoformans and this is most likely via its ability to release Pi from a broad range of 
physiological substrates, including potential immunomodulators, and to contribute to the 
maintenance of Pi homeostasis.  
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1 Introduction  
1.1 The fungal kingdom  
Fungi belong to one of the five kingdoms within the domain Eukarya, which include 
animals and plants. They exist in unicellular form (yeast) or in a filamentous form (mould) 
and are classified into phyla on the basis of their mode of sexual spore production (Prescott, 
2005). Fungi have some unique features that distinguish them from animals: they possess a 
cell wall and their major sterol is ergosterol, rather than cholesterol. Although antifungal 
drugs have been designed to exploit these unique features, they have certain limitations 
which are discussed in more detail below.  
Fungi are ubiquitous in nature and it has been estimated that up to 1.5 million fungal 
species exist, with approximately 90,000 species described to date (Prescott, 2005). In 
nature, fungi play an important role in decomposition and degradation of complex organic 
materials. Thus they are heterotrophic: obtain nutrients from external sources rather than 
by producing their own nutrition as in the case of auxotrophs (plants). They do this by 
secreting extracellular enzymes including phospholipases, proteases, cellulases and acid 
phosphatases. These enzymes break down the complex organic sources, yielding simple 
carbon, nitrogen and phosphorus sources for their nutrition and the nutrition of other soil-
dwelling organisms including plants (Murray, 2009). Fungi are also important for the human 
food industry, particularly in the manufacture of wine and cheese, and for the production of 
antibiotics, as they synthesize penicillin and cyclosporine (Prescott, 2005). However, some 
fungal species can be pathogenic and cause diseases in plants, animals and humans, and 
hence are widely studied in order to understand the mechanisms they use to cause disease. 
Most fungi that cause disease in humans are ascomycetes (produce ascospores) e.g. 
Candida and Aspergillus species, while Cryptococcus neoformans and Cryptococcus gattii are 
basidiomycetes (produce basidiospores). 
 
1.2 Medically significant fungi 
Most fungal pathogens of medical importance are opportunistic, or secondary 
pathogens as a compromised host immune system is the major pre-disposing factor for the 
establishment of Invasive Fungal Disease (IFD). People who are most at risk of developing an 
IFD are those with a compromised immune system, such as HIV patients, organ transplant 
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recipients taking immunosuppressive agents or corticosteroids, those with blood cancers 
(e.g. Leukemia) receiving chemo- or radio-therapy, and those with inherited severe 
immunodeficiency (Park et al., 2009), (Sun et al., 2002), (Klock et al., 2009), (Baddley et al., 
2011). Examples are Aspergillus fumigatus, Candida albicans and Cryptococcus neoformans, 
which cause the majority of cases of IFD (Prescott, 2005). Treatment of Candida and 
Aspergillus costs approximately 1.1 million/year in a single Australian haematology unit 
(Slavin et al., 2004). Estimates of the monetary cost of treating infections due to 
Cryptococcus neoformans in developing countries such as Sub-Saharan Africa and South East 
Asia are more difficult to calculate. However, the human cost is enormous (see below). In 
addition to the secondary pathogens there are a few fungi which are sufficiently virulent to 
be considered as primary pathogens; they cause IFD in immunocompetent as well as in 
immunocompromised individuals. Thus a compromised immune system is not a 
predisposing factor for these pathogens to cause IFD. These primary pathogens are able to 
avoid or subvert the normal host defence mechanisms and multiply within the host to cause 
IFD (Murray, 2009). Examples include Coccidioides immitis, Histoplasma capsulatum and 
Cryptococcus gattii. A recent outbreak of cryptococcosis in immunocompetent individuals in 
Vancouver Island, British Columbia, was caused by Cryptoccous gattii and resulted in 200 
cases of infection and 8 deaths (Fyfe et al., 2008). 
 
1.3  Antifungal treatments and their limitations 
Treating IFD is challenging as fungal and mammalian cells are both eukaryotic and therefore 
biologically similar. However, as mentioned above, fungi do have some differences, 
including a cell wall and a different major sterol (ergosterol), which have been exploited for 
development of two major classes of antifungal drugs: those targeting fungal ergosterol 
(Amphotericin B: AMB) or enzymes in the ergosterol biosynthetic pathway (terbinafine and 
azoles) and enzymes involved in cell wall biosynthesis (the echinochandins). A third class 
inhibits DNA/RNA synthesis and interferes with ribosomal protein synthesis (5-
fluorocytocine: 5-FC). Despite the development of these fungal target-specific drugs, these 
agents still have limitations. 
Azole-based antifungal agents, such as fluconazole, inhibit a key enzyme in the 
ergosterol biosynthetic pathway encoded by ERG11. Inhibition of Erg11 leads to the 
exhaustion of cellular ergosterol and the accumulation of toxic ergosterol precursors, which 
14 
 
when substituted for ergosterol in the fungal membrane, alter membrane structure and 
function (Ghannoum & Rice, 1999). In contrast to AMB, which is fungicidal, azoles are 
fungistatic, and can therefore lead to the development of resistance. Azoles however are 
less toxic than AMB and are therefore safer to use. Examples of acquired resistance to 
cryptococcal infections are found in developing countries where access to Highly Active 
Antiretroviral Therapy (HAART) and the full cohort of antifungal agents used in combination 
therapy is limited due to cost. In developed countries, drug resistance is minimized in 
patients with infections caused by C. neoformans by treating with a combination of AMB 
and 5-FC for the first two weeks, followed by a switch to the fungistatic azoles. However, in 
developing countries like Sub-saharan Africa, the cheaper azole drugs are often used 
inappropriately as a monotherapy and this has led to the development of resistance. Some 
fungal species (e.g. Scedosporium species) can also be inherently azole resistant. 
Long term use of AMB can lead to side-effects including hepatic and renal toxicity, 
or produce adverse effects when used in combination with other antimicrobials (Shapiro et 
al., 2011). Additionally, some antifungals do not exhibit broad specificity across fungal 
species. For example, the Echinocandin group targeting the cell wall, although well-
tolerated, are ineffective in treating cryptococcal infections. Morbidity and mortality from 
IFD can be decreased by making an early diagnosis so that treatment can start sooner. An 
example is cryptococcal meningitis which is fatal without treatment, with only 20% mortality 
even when appropriate treatment is received. Early detection of cryptococcal antigen with 
the Dip stick test can therefore improve the prognosis (Jarvis et al., 2011). In summary there 
is an urgent need to develop safer and more effective antifungals. Knowledge of the 
mechanisms of fungal development and pathogenicity is essential for development of novel 
antifungal drugs. 
 
1.4  Cryptococcus neoformans– an important human pathogen and fungal model  
C. neoformans is an opportunistic fungal pathogen causing approximately one million 
cases of infection and >600,000 deaths annually in HIV-infected patients alone (Park et al., 
2009) and there are more deaths from cryptococcal meningo-encephalitis in Sub-Saharan 
Africa than there are from tuberculosis (Park et al., 2009). C. neoformans mainly affects 
people who are immunocompromised but can also affect people with a competent immune 
system. Although such infections are rare, it has been reported that ~10% of patients 
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presenting with cryptococcal meningo-encephalitis in Vietman do not have HIV (Chau et al., 
2010). C. neoformans is the leading cause of fungal meningo-encephalitis worldwide. C. 
gattii on the other hand does not have as great a tendency to disseminate to the CNS and 
cause meningo-encephalitis, and is more geographically restricted than C. neoformans.  
C. neoformans is ubiquitous, with the main reservoir of infectious particles (spores or 
small desiccated yeast cells) being pigeon excreta, trees and soil. The infectious particles 
enter the host via the nasal passages after being inhaled from the environment (Figure 1.1.). 
Normally if the patient is immunocompetent, the infection is cleared from the lungs or 
potentially may reside in a dormant state inside macrophages within the lymph nodes. If the 
patient is immunocompromised, the pathogen can propagate in the lung tissue and cause 
pneumonia. From the lungs it can disseminate to the central nervous system (CNS) via the 
blood and lymphatic system to cause meningo-encephalitis. C. neoformans can survive and 
replicate in the extracellular environment (e.g., alveolar spaces, bloodstream) or it is 
engulfed by phagocytic cells (such as macrophages). Once inside phagocytic cells, C. 
neoformans can survive and replicate in the acidic phagolysome or it can be expelled back 
into the neutral/alkaline extracellular space without killing the host cells (Nicola et al., 2011). 
C. neoformans has also been found in the blood which is also of a more neutral pH. 
In addition to being a pathogen of medical relevance, many factors make C. 
neoformans an excellent model in which to study fungal pathogenesis. Firstly, its genome 
has been sequenced (Loftus et al., 2005). Secondly its genome is haploid and highly 
amenable to genetic manipulation, with protocols for carrying out targeted gene deletion, 
mRNA suppression and chromosomal and episomal gene expression being well-established. 
Thirdly, robust animal models of cryptococcal infection are well developed (Casadevall, 
1998). 
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Figure 1.1 Route of C. neoformans infection in the mammalian host.  
(Modified from (Hull & Heitman, 2002)). The infectious propagules are spores or small 
desiccated yeast cells. The main reservoirs for infectious propagules are soil, trees and 
pigeon excreta. Infectious propagules are inhaled from the environment and lodge in the 
alveoli. The yeast can then infect the lungs, causing pneumonia. From the lungs it can 
disseminate to the CNS via the blood and lymphatic system to cause meningo-encephalitis.  
1.5 C. neoformans virulence factors  
The virulence of a pathogen is defined as its infectiousness, or its ability to cause 
disease. Several factors contribute to the virulence of C. neoformans, including the ability to 
grow at host temperature (37˚C) and produce phospholipase B1, melanin and a 
polysaccharide capsule. Additional virulence-related traits include the production of the 
rigid cell wall and the ability to grow intracellularly (namely, inside macrophages). For a 
gene to be labelled as “associated with virulence”, it must satisfy the criteria defined by the 
“molecular Koch’s postulates”. These criteria include that (1) the phenotype associated with 
the gene in question is associated with pathogenic microbial species, (2) inactivation of the 
gene responsible for the pathogenic phenotype results in decreased virulence, and (3) 
restoration of the intact gene is associated with reversion to wild-type virulence (Falkow, 
1988).  
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1.5.1 Growth at host temperature (37°C) 
In order for the fungi to thrive inside the host, they must be able to adapt to the host 
temperature. Several sensing and adaptation mechanisms have been identified in C. 
neoformans. These include the calcineurin and RAS signalling pathways (Nichols et al., 2007), 
(Waugh et al., 2002), (Kraus et al., 2005, Alspaugh et al., 2000). Our laboratory has 
demonstrated significance of the enzyme phospholipase C1 (PLC1) for growth of C. 
neoformans at physiological temperature (Chayakulkeeree et al., 2008).  
1.5.2 Melanin  
In the presence of a suitable precursor and a poor nutritional environment, C. 
neoformans produces an extracellular, black, negatively charged pigment melanin 
(Williamson, 1994), (Casadevall et al., 2000). Melanin supports the cryptococcal cell wall, 
and is protective against host-derived oxidative stress, extreme temperature, UV irradiation 
and phagocytosis by host macrophages (Casadevall et al., 2000, Casadevall, 1998). Melanin 
is produced from host- or soil-derived phenolic compounds, for example epinephrine and L-
dopa, and its biosynthesis is catalysed by a cell wall associated enzyme laccase. Laccase is 
therefore an important virulence factor of C. neoformans (Salas et al., 1996, Pukkila-Worley 
et al., 2005, Williamson, 1994) 
1.5.3  Polysaccharide capsule  
The most unique virulence factor of C. neoformans is the extracellular polysaccharide 
capsule, which also determines cryptococcal serotype. The two main capsule components 
are the polysaccharides glucuronoxylomannan (GXM) and glucuronoxylomannogalactan 
(GXMGal); GXM accounts for 90-95% of the capsule’s mass (Zaragoza et al., 2009). Capsule 
formation is induced under environmentally stressful conditions to protect cryptococcal 
cells from environmental challenges and desiccation. During host infection, the capsule 
protects C. neoformans from engulfment by macrophages and enables cryptococcal cells to 
evade the immune response by shielding cell wall antigens. Moreover, the capsule affects 
cytokine production, inhibits leukocyte migration to cryptococcal infection sites and 
depletes components of the complement in the host.  It also assists C. neoformans to 
disseminate from the lungs to the CNS (Vecchiarelli & Monari, 2012), reviewed in (Garcia-
Rodas et al., 2011). Polysaccharide capsule is a dynamic structure that can change in size 
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and undergoes rearrangement during budding (McFadden et al., 2006). Changes in capsular 
structure are also associated with phenotypic switching in C. neoformans (Guerrero & Fries, 
2008, Jain et al., 2006b). Alteration from a smooth to a mucoid colony phenotype, 
associated with increased production of capsular material, caused hypervirulence and 
increased intracerebral pressure in a rat model of cryptococcal meningitis (Fries et al., 2005, 
Jain et al., 2006a) 
1.5.4 Phospholipases  
Phospholipases are a group of enzymes that hydrolyse one or more ester linkages in the 
phospholipid backbone of glycerophospholipids. Phospholipases are categorised into 5 
groups based on the ester bond that they cleave: A1, A2, B, C, and D (reviewed in 
(Ghannoum, 2000)).The two major phospholipases associated with the virulence of C. 
neoformans are phospholipase B (PLB1) (Chen et al., 2000) and phospholipase C (PLC1) 
(Chayakulkeeree et al 2007) reviewed in (Djordjevic, 2010). In C. neoformans, PLB1 is a 
secreted protein (Djordjevic et al., 2005), (Siafakas et al., 2007), (Siafakas et al., 2006)). PLB1 
has three catalytic activities directed towards its major substrate, phosphotidylcholine (PC): 
phospholipase B (PLB) lysophospholipase (LPL) and lysophospholipase-transacylase (LPTA) 
(Chen et al., 2000). The PLB and LPL activities cleave fatty acids from a phospholipid and 
lysophospholipid respectively, while the LPTA activity transfers a free fatty acid to a 
lysophospholipid to produce a phospholipid. 
 
1.6 Acid phosphatases  
1.6.1 Phosphate utilization by fungi and the role of Acid Phosphatase  
Phosphorus in the form of inorganic phosphate (Pi) is an essential nutrient for all 
living things. Intracellular Pi is essential for the synthesis of macromolecules, including ATP, 
phospholipids, and proteins, and is involved in numerous signalling and metabolic processes. 
In order to synthesize these molecules, millimolar concentrations of phosphate are needed 
in the cytoplasm, while most environmental Pi concentrations are considerably lower. Acid 
phosphatases are a family of enzymes that catalyse the hydrolysis of phosphate monoesters 
bound up in complex organic sources, releasing free Pi. They work optimally in acidic 
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conditions (pH 4.5-5.5) (Anand & Srivastava, 2012). To concentrate Pi inside the cytoplasm, 
fungi deploy membranal Pi transporters to transport Pi into the cell (Wykoff & O'Shea, 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When intracellular phosphate is low, Pi responsive genes are induced to produce secreted 
acid phosphatase and other proteins involved in Pi mobilization, such as phosphate 
transporters. Secreted acid phosphatase frees up Pi from complex organic sources which are 
too big to cross the membrane and cell wall. This free Pi is transported across the membrane 
and cell wall via the transporters and mixes with the intracellular pool of Pi. Intracellular Pi is 
either stored (as polyphosphate) or used in the various physiological processes depicted. 
High intracellular Pi also shuts down the expression of secreted acid phosphatase and the Pi 
transporters.   
 
1.6.2 The PHO pathway in the model yeast Saccharomyces cerevisiae 
In the model non-pathogenic yeast, S. cerevisiae, Pi homeostasis is regulated by the 
phosphate (PHO) signal transduction pathway (PHO pathway). The PHO pathway consists of 
3 main components (1) the PHO regulation system which is a signalling cascade comprised 
of kinases and transcription factors, which up or down-regulate the PHO responsive genes 
Figure 1.2 Phosphate homeostasis is essential for cellular function. 
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according to the level of intracellular Pi (Tomar & Sinha, 2014); (2) PHO responsive genes, 
including secreted acid phosphatase Pho5 and a membrane transporter system comprising 
low- and high affinity Pi transporters, which allow S. cerevisiae to internalize extracelluar Pi 
and (3) Pho-responsive genes encoding enzymes involved in utilizing intracellular 
polyphosphate reserves. The PHO pathway receives and responds to signals from both the 
extra and intracellular environment and functions to maintain Pi homeostasis and to 
optimize Pi uptake and utilization. It is activated during Pi starvation (Oshima, 1997) (Figure 
1.3). 
In S. cerevisiae, the PHO regulation system consists of the cyclin-dependent kinase inhibitor, 
Pho81, the cyclin - cyclin-dependent kinase complex, Pho80-Pho85 and the transcription 
factors, Pho4 and Pho2. Under low-Pi conditions, Pho81 represses the Pho80-Pho85 
Figure 1.3: The PHO pathway is activated in low phosphate conditions. 
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complex, which in turn leads to hypo-phosphorylation of the transcription factor Pho4. 
Hypo-phosphorylation Pho4 in turn activates PHO genes, including the high affinity 
transporters (Pho84, Pho89) and secreted acid phosphatases (Pho5, Pho11 and Pho12). 
(Lenburg & O'Shea, 1996), (Oshima, 1997), (Persson et al., 2003). 
1.6.3 Classification of acid phosphatases, substrate specificity and function  
Most acid phosphatases belong to the histidine phosphatase superfamily, which have 
a conserved catalytic core centred on a histidine (Rigden, 2008). The histidine phosphatase 
superfamily is divided into two branches. The ‘phosphoglycerate mutase family’ forms 
branch 1, while branch 2 contains mainly the ‘acid phosphatases and phytases’ (Rigden, 
2008), which remove phosphate from inositol phytate/hexakisphosphate/IP6. Phytate is the 
major storage form of phosphorus in soil and plants, and exists primarily as a complex with 
Ca2+, Fe2+, and Zn2+, which are cations important in nutrition. Thus, phytase-mediated 
hydrolysis of phytate leads to the formation of less complex inositol phosphates and inositol, 
and thus increases the bioavailability of Pi and minerals important for growth and 
development of plants and animals. Eukaryotic Minpp1 (multiple inositol-polyphosphate 
phosphatase 1) regulates the cellular concentration of inositol pentakisphosphate (IP5) and 
IP6 (Chi et al., 2000). 
Branch 2 acid phosphatases include bacterial and eukaryotic enzymes. In E. coli, 
periplasmic glucose-1-phosphatase is required for growth on glucose 1-phosphate as a sole 
carbon source (Pradel & Boquet, 1991). Human prostatic acid phosphatase (PAP) hydrolyses 
lysophosphatidic acid in seminal plasma (Tanaka et al., 2004). Phosphorylation and signalling 
of the receptor tyrosine kinase, ErbB2, can be regulated by prostatic acid phosphatase 
(Anand & Srivastava, 2012). Another acid phosphatase, ACPT, acts as a tyrosine phosphatase 
to modulate ErbB4 receptor-mediated signalling important for neuronal development and 
synaptic plasticity (Fleisig et al., 2004). Tartrate-resistant acid phosphatase, TRAP, plays role 
in primary immune responses and bone remodelling (Anand & Srivastava, 2012). In the 
fission yeast Schizosaccharomyces pombe, production of a cell-surface acid phosphatase is 
repressed by thiamine suggesting a role in thiamine metabolism, possibly in the cleavage of 
a thiamine phosphate (Rigden, 2008).  
An important functional characteristic of an enzyme is its catalytic activity towards 
different substrates and its substrate specificity (Anand & Srivastava, 2012). Depending on 
22 
 
the range and type of substrate it is able to catalyse, we are able to make assumptions of its 
biological and physiological significance and/or determine its role. Acid phosphatases are 
known to be able to catalyse a wide range of physiological substrates including energy 
storage molecules and phosphorylated sugars and amino acids (Anand & Srivastava, 2012).  
 
1.6.4  Role of acid phosphatases in microbial pathogens  
Extracellular acid phosphatases are produced by many microbial species, including the 
bacterial pathogens, Mycobacterium tuberculosis (Puri et al., 2013) and Legionella micdadei 
(Saha et al., 1988), the protozoan parasites, Leishmania donovani (Shakarian et al., 2002) 
and Trypanosoma cruzi (Meyer-Fernandes et al., 1999) and the fungal pathogens Candida 
albicans (Portela et al., 2010), Candida parapsilosis (Kiffer-Moreira et al., 2007a), Sporothrix 
schenckii (Arnold et al., 1986), Aspergillus fumigatus (Bernard et al., 2002), Fonsecaea 
pedrosoi (Kneipp et al., 2003, Kneipp et al., 2004), Rhinocladiella aquaspersa (Kneipp et al., 
2012), Pseudallescheria boydii (Kiffer-Moreira et al., 2007b), Paracoccidioides 
brasiliensis (Xander et al., 2007) (for review see (Gomes et al., 2011)) and Cryptococcus 
neoformans (Vidotto et al., 2006).  
Secreted acid phosphatase (SAP) produced by M. tuberculosis is essential for 
pathogenesis and allows the bacteria to evade detection by the host immune system by 
preventing maturation of the macrophage phagosome (Puri et al., 2013). Interestingly, SAP 
is more homologous to fungal acid phosphatases than to those of bacterial origin, 
suggesting that the encoding gene has been acquired from fungi during the bacterial 
evolutionary process, and further highlighting the importance of fungal acid phosphatases in 
microbial pathogenesis. Legionella micdadei, which has adjusted to survive and multiply 
within phagocytic cells, was shown to block superoxide anion production by human 
neutrophils, possibly via hydrolysis of neutrophil derived phosphatidylinositol 4,5-
bisphosphate and its secondary messenger hydrolysis product, IP3 (Saha et al., 1988). 
Similarly, constitutively-expressed surface acid phosphatase produced by the protozoan, L. 
donovani, which also resides and multiplies within macrophage phagolysosomes, inhibited 
superoxide anion production by human neutrophils (Remaley et al., 1984) (Shakarian et al., 
2002). 
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 In the fungal pathogens Candida parapsilosis (Fernanado et al., 1999, Kiffer-Moreira 
et al., 2007a) Fonsecaea pedrosoi (Kneipp et al., 2003, Kneipp et al., 2004)) and 
Rhinocladiella aquaspersa (Kneipp et al., 2012), surface acid phosphatase activity 
contributes to adhesion of the fungal cells to the host cells, a process essential for 
subsequent infection. The phosphorylation and dephosphorylation of serine, threonine and 
tyrosine residues in extracellular domains of functionally important surface proteins of the 
host may be a mechanism defining the outcome of host-pathogen interaction (Belanger et 
al., 2002). 
Extracellular acid phosphatase activity has also been detected in over 95% of 310 C. 
neoformans strains isolated from AIDS patients in 5 different countries (Vidotto et al., 2006), 
suggesting that acid phosphatases may also be associated with cryptococcal virulence. 
(Collopy-Junior et al., 2006) demonstrated that adhesion of C. neoformans cells to animal 
epithelial cells was reduced following non-specific irreversible inhibition of acid phosphatase 
activity by sodium orthovanadate. However, the enzymes responsible for this activity were 
never identified.  
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Thesis Aims 
The overall aims of this thesis are to determine whether acid phosphate (Aph1) is 
responsible for the extracellular acid phosphate activity produced by a strain of 
Cryptococcus neoformans (H99) isolated from a patient with AIDS, characterise its mode of 
regulation and function, and determine its contribution to fungal virulence.  
The specific aims are to: 
1. Delete the APH1 gene, which is predicted to encode a secreted protein (Aph1), using 
a targeted gene deletion strategy, to create the strain Δaph1. 
Then, by comparing the phenotypes of WT and Δaph1, determine: 
2. Whether Aph1 contributes to extracellular acid phosphatase activity using a 
chromogenic assay ; 
3. Whether Aph1 transcription and secretion is regulated by Pi availability; 
4. Which phosphorylated substrates Aph1 hydrolyses  
5. Whether Aph1 is essential for production of cryptococal virulence traits (melanin,  
capsule and ability to grow at human physiological temperature 37°C), resistance to 
stress and growth in the absence of an external source of phosphate  
6. Whether Aph1 contributes to pathogenesis using wax moth and mouse inhalation 
infection models 
7. Whether Aph1 facilitates adhesion of C. neoformans to a lung epithelial cell line  
8. The effect of APH1 absence on the expression of other APase-encoding genes and 
whether these genes are also regulated at the transcriptional level by Pi availability. 
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2 Material and Methods 
2.1 General Reagents, Media and Stock Solutions  
2.1.1 Preparation of Media and Stock Solutions  
Procedures for all media and stock solutions are listed in Appendix 1. Water 
acquired from the Milli-Q Integral Water Purification System (EMD Millipore Corporation, 
MA, USA) was used to prepare all media and stock solutions. pH of media and solutions was 
determined using a pH meter. All media were sterilised by autoclaving and all stock 
solutions were filter sterilised through a 0.22 μM filter (Appendix 2).  
 
2.1.2 Commercial Reagents  
All commercially available products, kits, chemicals, enzymes and antibodies used 
in this thesis are listed in Appendix 2. 
2.2  Strains  
The Cryptococcus neoformans strain used for all experimental work in this thesis 
was Cryptococcus neoformans var. grubii H99 (serotype A); 
(https://www.broadinstitute.org/annotation/genome/cryptococcus_neoformans/MultiHom
e.html) (Mitchell et al., 1995). This strain is referred to as wild type (WT) H99 and was used 
to create the APH1 deletion mutant.  
WT H99 and the APH1 gene deletion mutant strain (Table 1) were cultured from 
frozen 20% glycerol stock on Sabouraud Dextrose Agar (SAB) (Appendix 2) plates at room 
temperature (RT) for 72 hours. Plates were stored inverted at 4°C. Fresh cultures were 
prepared from frozen glycerol stocks weekly to fortnightly. 
 
Table 1. Strains used in this thesis 
Strain Serotype Name Genotype 
H99 A                      WT            H99 WT 
H99            A Δaph1 Δaph1:NEO 
*The coding region of the APH1 gene has been replaced by the NEO resistance cassette. 
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2.3  Polymerase Chain Reaction (PCR) 
PCR Amplification from Genomic DNA  
PCR reactions (for construction of the deletion construct and verifying targeted 
gene deletion) were performed using genomic DNA extracted from C. neoformans as a 
template and the high-fidelity TaKaRa Ex Taq polymerase enzyme (Appendix 2). The PCR 
mixture (50 µl) was prepared in a 0.2 ml PCR tube as follows: 0.25 µl of TaKaRa Ex Taq (5 
units/µl), 5 µl of 10X Ex Taq Buffer, 4 µl of dNTP Mix (2.5mM each), 2.5 µl each of forward 
and reverse primer (20 µM), 1 µl of DNA template (100-500 ng) and 34.75 µl of UltraPure 
water. The final concentrations of each dNTP and each primer were 0.2 mM and 1 µM, 
respectively. The thermal cycler (Biometra, Goettingen, Germany) was initially set up as 
shown below, with the annealing temperature and/or extension temperature altered when 
applicable depending on the primers and PCR product size. 
 
Initial denaturation                   95°C  5 min                   
Denaturation                              95°C  30 sec 
Annealing                                    55°C  30 sec                                        35 cycles 
Extension                                    72°C  1 min/kb of PCR product 
Final extension                           72°C  10 min                  
 
To visualize the PCR products, the PCR mixtures were subjected to agarose gel 
electrophoresis as described in section 2.4. 
 
2.4 Agarose Gel Electrophoresis and Visualization of DNA  
DNA including PCR products were visualized by agarose gel electrophoresis and 
SYBR Safe DNA gel staining (Appendix 2). The agarose gel was prepared by dissolving 1.5% 
(w/v) agarose (Appendix 2) in 1X Tris-borate-EDTA (TBE) buffer (Appendix 2) by heating in a 
microwave oven, following by the addition of 1μL SYBR Safe DNA Gel stain per 10ml of liquid 
agarose gel and pouring of the gel into a gel tray containing a comb. When the gel had 
cooled and solidified, the comb was removed and the entire casting tray was lowered into 
SUB-CELL GT electrophoresis tank (Bio-Rad Laboratories Pty. Ltd., NSW, Australia) and 
covered with TBE buffer. A total of 10 μl of the PCR reaction was mixed with 2 μl of 6X 
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Blue/Orange Loading Dye (Appendix 1) and loaded into each well of the agarose gel. To 
determine the size of the DNA fragments, 10 μl (1 μg) of 1kb DNA Ladder (Appendix 2) were 
loaded into a well of the same agarose gel before electrophoresis was started. Gel 
electrophoresis was performed by applying an electric current to the tank at 100 V for 1 h 
(may vary depending on the product size). Product was then visualized using a Safe Imager 
blue light transilluminator (Invitrogen, CA, USA). 
 
2.5  Extraction of C. neoformans Genomic DNA  
C. neoformans strains (WT or △aph1) were cultured at 30°C for 3 days on YPD agar. 
Approximately 2-3 loopfuls of yeast cells were transferred from the plates to a 2-ml screw-
capped microfuge tube containing 0.5 ml of acid-washed glass beads (0.5 mm in diameter) 
and 0.5 ml of TENTS buffer (see Appendix 2). The tubes were vortexed vigorously for 2 x 30 
sec with a 1 min cooling period on ice in between each vortex and following the final vortex. 
Five hundred µl of phenol:chloroform:isoamyl alcohol (IAA) (25:24:1) was added to each 
tube followed by vigorous vortexing as above. The tubes were centrifuged at maximum 
speed at 4°C for 15 min to achieve a phase separation. The supernatants were transferred 
to a fresh microfuge tube and 500 µl of phenol:chloroform:IAA (25:24:1) was added 
followed by vigorous vortexing for 30 sec. The tubes were centrifuged as above to achieve 
phase separation, the supernatants were transferred to a fresh microfuge tube and 500 µl 
of chloroform was added, followed by vortexing. The tubes were centrifuged as above to 
achieve phase separation and the supernatants (approximately 500 µl) were transferred to a 
fresh microfuge tube. DNA precipitation was achieved by adding 50 µl of 3M sodium acetate  
(1/10 volume) and 1.25 ml of absolute ethanol (2.5 volume). The tubes were incubated at 
4°C for at least 1 hour or overnight. The tubes were centrifuged as above to collect the 
precipitated DNA and the pellets were washed once with 70% ethanol. Finally, DNA was re-
suspended in TE buffer (Appendix 2) or 10 mM Tris (pH 7.5) and used for PCR as described 
above. 
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2.6 Targeted Deletion of the APH1 Gene in C. neoformans  
2.6.1 Construction of an APH1 deletion construct by overlap PCR  
APH1 (CNAG 02944) was selectively deleted in C. neoformans strain H99 (Wild-Type, 
WT). This was achieved by making an APH1 gene deletion construct in vitro using overlap 
PCR, and introducing it into WT C. neoformans using biolistic transformation where it could 
replace the native APH1 gene by homologous recombination. All PCR amplifications were 
performed using a high-fidelity polymerase ExTaq (Appendix 2) as described in section 2.3. 
To create the deletion construct, genomic DNA from C. neoformans was prepared as 
described in section 2.5, and flanking sequences upstream (5’flank, 787bp) and downstream 
(3’flank, 952 bp) of the coding region of the APH1 gene (designated as CNAG_02944 in the C. 
neoformans H99 serotype A genome database) were amplified by PCR in separate reactions, 
using primer pairs APH1-1F/APH1-2R and APH1-3F/APH1-4R respectively (Section 2.2, Table 
1). Simultaneously, and in a separate reaction, the neomycin resistance (NEOR) cassette was 
amplified from the pJAF vector using primers NEOF and NEOR (Figure 3.3 and Section 2.6.2, 
Table 2.). Each PCR product was confirmed to be of the correct size using electrophoresis on 
a 0.8% agarose gel and SYBR safe staining, as described in section 2.4, and then purified 
using a Promega Gel Extraction Kit. The three purified PCR products (5’ flank, Neor cassette 
and 3‘ flank), which contained overlapping ends, were combined in a single tube to provide 
a template for overlap PCR using primers APH1-1F/APH1-5R (Figure 3.3, Section 2.6.2, Table 
2.). The final product, which was approximately 3 kb in size, was gel-purified as described 
above for the single PCR products, and used to transform strain H99 using a biolistic DNA 
delivery protocol (section 2.6.2). 
2.6.2  Biolistic Transformation  
The delivery of the APH1 deletion construct into the WT C. neoformans (H99) strain 
was achieved by biolistic transformation using the method of (Toffaletti et al., 1993) with 
minor modifications. Ten ml of an overnight YPD culture of H99 was concentrated to 
approximately 300 µl by centrifugation and spread onto a YPD agar plate containing 1 M 
sorbitol. The following reagents were added to 200 ng of the gel-purified deletion construct 
prepared in 2.6 (the amount used for one bombardment) with continuous mixing and in the 
following order: 10 µl of 0.6 µm gold bead microcarrier suspension (Appendix 2), 10 µl 2.5M  
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CaCl2 and 2 µl 1M spermidine. The amount of DNA and reagents were scaled up 
accordingly when more than one bombardment was carried out. The DNA was allowed to 
precipitate onto the beads for 10 min without agitation. The DNA-coated gold beads were 
pelleted by centrifugation, the supernatant was removed and the pellet washed with 250 µl 
absolute ethanol. The final pellets were resuspended in 10 µl absolute ethanol per 
bombardment. For each bombardment, 10 µl of the DNA/gold bead suspension was spread 
onto the centre of the macrocarrier disc and allowed to dry. Particle delivery from the 
macrocarrier disc to the cell culture lawn was carried out using the biolistic PDS-1000/He 
system (Bio-Rad Laboratories Pty. Ltd., NSW, Australia) once the vacuum in the chamber 
had reached 28.5 inches Hg. Activation of the firing mechanism allowed the pressurized 
helium gas to break the 1350-psi rupture disk, generating a helium shockwave into the 
bombardment chamber. The shock wave hits the macrocarrier disc and propels the adhered 
DNA-coated gold bead microcarriers toward the target cells. A stopping screen placed 
between the macrocarrier assembly and the target cells, retains the macrocarrier, allowing 
the DNA-coated gold microprojectiles to pass through and transform the target cells on the 
agar plate. After bombardment, the plate was incubated at 30oC for 2-3 hours to allow 
recovery. The transformed cells in the middle of the plate (having an orange appearance 
due to the gold beads) where then dislodged with a scraper, mixed with 1 ml of 1M sorbitol 
and spread onto a selective YPD agar plate containing 100 µg/ml of geneticin 
(G418)/neomycin. The plate was incubated for 4-5 days at 30oC to allow the transformants 
to grow. The colonies that grew were transferred to fresh YPD agar plates without the 
selective drug and subcultured a further 3 times in non-selective medium before being 
inoculated back onto YPD/G418 agar. Mitotically-stable transformants were screened for 
the absence of extracellular acid phosphate activity as described in 2.7.1. (Figure 3.4.)  and 
by PCR as described in 2.3 (Figure 3.5) to confirm that the deletion construct had undergone 
homologous recombination into the native APH1 locus. PCR-verified transformants were 
designated ∆aph1. 
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Table 2. List of primer sequences used for C. neoformans APH1 gene deletion 
Primer  Type Sequence 
APH1-1F Forward 5’-CAGCCGGGAAGAGATAA-3’ 
APH1-2R Reverse 5’CTCCAGCTCACATCCTCGCAGGACGGTGTTTTTGGGTGAGT-3’ 
APH1-3F Forward 5’-CCTCAGGATCTTCATGGCTCCTTATGGGCGTGCTCCTC-3’ 
APH1-4R Reverse 5’-CCCTCTGCTCCATACGATTT-3’  
APH1-OTS5’  
APH1-OTS3’  
Reverse 
Reverse 
5’-CCTCTTGTAGCCGACGAATAAAT-3’ 
5’-GAATCACCACACTCGACGCG-3’ 
NEOF Forward 5’-CATGCAGGATTCGAGTGGCATG-3’ 
NEOR Reverse 5’-GGAGCCATGAAGATCCTGAGGA-3’  
 
2.7 Acid phosphatase activity assay using para-nitrophenol phosphate (pNPP) 
2.7.1 Screening neomycin-resistant transformants for lack of extracellular acid 
phosphatase activity to identify Δaph1 mutants  
Each transformant was inoculated into 100 l phosphate-deficient (inducing) 
medium MM-KCl (0.5% KCl, 15 mM glucose, 10 mM MgSO4.7H20, 13 mM glycine, 3.0 uM 
thiamine) to maximize the production of acid phosphatase, and grown overnight in a 96 well 
plate. The chromogenic substrate, pNPP (50 mM Stock) was then added to each well to a 
final concentration of 10 mM and incubation was resumed at 37°C for 20 min. The reactions 
were stopped by addition of 50 l of saturated Na2CO3. Wells containing mutants that had 
not turned yellow (remained clear) were considered as candidate APH1 gene deletion 
mutants. 
2.7.2 Measuring extracellular acid phosphatase activity produced by WT and Δaph1-1 
C. neoformans strains (WT and ∆aph1-1) were grown overnight in YPD broth. The 
cells were washed with water and resuspended in either acid phosphatase suppressing 
medium (with phosphate); MM-KH2PO4 (0.5% KH2PO4, 15 mM glucose, 10 mM MgSO4.7H20, 
13 mM glycine, 3.0 uM thiamine) or inducing medium MM-KCl (without phosphate) (see 
recipe above) at OD600=1. The cultures were incubated at 30°C for 3 hours. Following 
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incubation, 16 x 50 ul aliquots of each culture were removed and assayed for acid 
phosphatase production as follows: the cells in each aliquot were pelleted by centrifugation 
at 14, 000 x g, resuspended in 400 l of 50 mM sodium acetate (pH 5.2) containing 2.5 mM 
p-nitrophenyl phosphate and incubated at 37°C. At 5 min intervals over an 80 min time 
period, the reaction in a single aliquot of induced and non-induced culture was stopped by 
adding 800 μL of saturated Na2CO3. Cells were again pelleted by centrifugation and the OD 
of the supernatant was measured spectrophotometrically at 420 nm to determine the 
extent of pNPP hydrolysis. The pNP hydrolysis product is yellow and absorbs maximally at 
405 nm. The assay was performed in duplicate. 
 
2.8 Assessing Aph1 substrate specificity using the Malachite Green Assay  
To identify substrates of Aph1, the malachite green assay was performed in a 96 well 
plate according to the manufacturer’s instructions (Cayman chemical). The Malachite Green 
assay is a quick and reproducible method for measuring free inorganic phosphate in 
aqueous solutions, including that released by acid phosphatases. The assay is based on the 
formation of a complex between malachite green molybdate and free orthophosphate that 
absorbs at 620-640 nm (Cayman chemical). 
WT and ∆aph1-1 strains were taken out of glycerol stock, grown overnight on SAB 
plates at 30°C and inoculated to an OD600 =1 in MM-KCl (low phosphate) medium. The 
strains were then grown overnight at 30°C with shaking (200 rpm) to allow induction of 
APH1 expression in the WT. The cells were centrifuged at maximum speed for 2 min. Each 
supernatant was collected as the source of enzyme for the assay and a master mix was 
prepared which contained 250 l of enzyme (or 250 l ultra-pure free water to serve as a 
no-enzyme control), 33.5 l of 3M sodium acetate (pH 5.2) and 716.5 l of water. Each 
reaction contained master mix (25 l) and 25 l of 10 mM substrate. The reactions were 
incubated at 37°C with shaking for 40 min (Figure 3.8A) or for 60 min, with readings taken 
every 10 min (Figure 3.8B and C). Following incubation for the indicated times, 10 l of the 
reaction (containing 2.5 l of the original enzyme) was combined with 40 l of water, and 5 
l of MG Acid Solution was added. The tube was mixed by gentle tapping, incubated for 10 
min at room temperature and 15 l of Malachite Green (MG Blue Solution) was then added. 
Following mixing, the tubes were then incubated for 20 min at room temperature. During 
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the incubation with MG Blue, each reaction including the ‘no enzyme’ control was 
transferred to a 96 well plate. After the incubation the absorbance was determined using a 
microplate reader at 650nm. The amount of inorganic phosphate produced and hence, the 
Aph1 substrate preference, was determined using a standard curve which was set up 
according to the manufacterer’s instructions. Each result was corrected by subtracting the 
absorbance obtained for the no enzyme control which was a measure of the spontaneous 
breakdown of substrate. 
 
2.9 Adhesion assay 
The adherent lung epithelial cell line, A549, was seeded into 24 well plates at a 
concentration of 1.3 x 105 cells/ml/well in RPMI/10% foetal calf serum and incubated 
overnight at 37°C in a 5% CO2 atmosphere. WT and ∆aph1-1 were grown overnight in Aph1 
inducing medium (MM-KCl, no phosphate) using inoculum from a freshly grown SAB plate. 
The fungal cells were washed with water, counted  and resuspended at a concentration of 5 
x 106 cells per well in the 2 day-old (spent) A549 cell culture medium. Spent medium was 
used instead of fresh medium to ensure that phosphate remained depleted and, hence, that 
levels of secreted Aph1 remained high during the adhesion assay. Cryptococcal cells were 
then added to the A549 monolayers and incubation was carried out for 2 h. The media was 
then aspirated and the monolayer washed 3 times with PBS to remove unbound C. 
neoformans cells. After washing, 0.05% SDS was added to the monolayer to dislodge the 
cryptococcal cells from the A549 monolayer. At this concentration of SDS, the A549 cells are 
lysed while the cryptococcal cells remain intact (Voelz et al., 2010). The mixture was then 
plated out onto SAB plates and the number of colony forming units (CFUs) determined 
following 2 days incubation at 30°C.  
 
2.10 Survival Studies 
2.10.1  Galleria mellonella infection model  
C. neoformans WT, ∆aph1-1 and ∆aph1-2 cells were grown overnight, pelleted by 
centrifugation, and resuspended in water at a concentration of 108 cells/ml. G. mellonella 
larvae (10 to 20 per strain) were inoculated with 10 l of cell suspension (106 yeast cells) by 
injection into the hemocoel via the lower pro-legs. The viability of each inoculum was 
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assessed by performing serial 10-fold dilutions, plating the dilutions onto Sabouraud (SAB) 
agar plates, and counting the CFU after a 3-day incubation at 30°C. Inoculated larvae were 
monitored daily for 13 days. The Kaplan-Meier method in the SPSS statistical software 
program (version 20) was used to estimate the differences in survival (log rank test) and to 
plot the survival curves. In all cases, a p value of less than 0.05 was considered statistically 
significant. 
2.10.2  Murine inhalation model of cryptococcosis. 
All procedures described were approved and governed by the Sydney West Local 
Health District Animal Ethics Committee, Department of Animal Care. Survival analysis was 
conducted using 7-week-old female BALB/c mice obtained from the Animal Resource Centre, 
Floreat Park, Western Australia, Australia. The mice were anesthetized using isoflurane (in 
oxygen) delivered via an isoflurane vaporizer attached to a Stinger small animal anesthetic 
machine (Advances in Anaesthesia Specialists). Groups of 10 to 20 mice were then 
inoculated intranasally with C. neoformans WT, ∆aph1-1 or the ∆aph1-2 mutant strain 
(5x105 yeast cells in 20 μl phosphate-buffered saline [PBS]) and observed daily for signs of ill 
health. Numbers of viable yeast cells inoculated into the nares were later confirmed by 
quantitative culture. Mice which had lost 20% of their pre-infection weight, or which 
showed debilitating clinical signs prior to losing this weight, including hunching, respiratory 
distress, excessive fur ruffling, or sluggish/unsteady movement, were deemed to have 
succumbed to the infection and were euthanized by CO2 inhalation followed by cervical 
dislocation. Differences in survival were determined with SPSS (version 20) statistical 
software, using the Kaplan-Meier method (log rank test), where a p value less than 0.05 was 
considered statistically significant. 
 
2.11 Drop Dilution Assays  
2.11.1 Cell preparation and dilution 
All C. neoformans strains were grown overnight in Yeast Extract Peptone Dextrose 
(YPD) broth (Appendix 2) at 30°C. Following incubation, cells were centrifuged at 4,766 x g 
for 10 min after which the cell pellet was re-suspended in fresh YPD broth. Serial 10-fold 
dilutions of each strain were prepared with distilled water (106-101 cells/3μL)  
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2.11.2 High-Temperature Growth Assay  
3 μL of each dilution prepared in 2.12.1 were dropped onto YPD agar and the plates 
were inverted and incubated at 30°C (control) and 37°C for 72 hours, after which growth 
was recorded and photographed. 
2.11.3 Cell Wall Integrity and high salt stress assay  
For the assay 3 μL of each dilution prepared in 2.12.1 was dropped onto YPD agar 
containing, 1.5 mg/ml Calcofluor White (Fluorescent Brightener 28), 0.8 M NaCl, 0.5% Congo 
Red or 0.01% SDS (Appendix 2). Except for NaCl, these substances are all cell wall perturbing 
agents. A YPD agar plate containing no cell wall perturbing agent was used a control. All 
plates were inverted and incubated at 30°C for 72 hours after which growth was recorded 
and photographed. 
 
2.12 Capsule Production Assay  
2.12.1  Capsule Induction  
All C. neoformans strains were grown, prepared and serially diluted as in 2.11. Each 
dilution was dropped onto RPMI-1640 agar (pH 7.0). Plate were inverted and incubated at 
37°C within a 5% CO2 atmosphere (to mimic conditions in vivo) for 4 days. Cells were 
scraped from the plate, counter-stained with India Ink, and capsule production was assessed 
under a light microscope. Images were then captured at 100x magnification.  
 
2.12.2 Measurement of Capsule Size  
The images obtained in Figure 3.12 were viewed using ImageJ 1.45s software. The 
diameter of the whole cell (including capsule) and cell body was then measured on 40 cells. 
The average capsule:cell body ratio was calculated using the following formula: diameter of 
the cell including capsule/diameter of the cell body.  
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2.13 Determining APH mRNA expression levels by semi-quantitative real time PCR (q-
PCR)  
2.13.1  Inducing APH gene expression 
WT and ∆aph1-1 were grown overnight in YPD, washed and incubated for 3 hours 
in inducing (MM-KCl) or suppressing (MM-KH2PO4) medium and then snap-frozen in liquid 
nitrogen.  
2.13.2  RNA extraction and purity assessment  
The cells prepared above were homogenized by bead beating using the mini bead 
beater (Mini bead beater-8 BIOSPEC PRODUCTS) in the presence of glass beads and TRIZOL® 
(Ambion) and RNA was extracted and precipitated from the aqueous phase. Briefly, 0.5ml of 
isopropyl alcohol per 1ml of TRIZOL® reagent was added to precipitate out the RNA. 
Samples were incubated at RT for 10 min and centrifuged at 12000 x g for 10 min at 4°C. 
Supernatants were removed and the RNA pellets were washed with 1ml 75% ethanol per 
1ml of TRIZOL® reagent, followed by centrifugation at 7600 x g for 3 min at 4°C. 
Supernatants were removed and the RNA pellet was air-dried for 5-10 min. Depending on 
RNA pellet size, the pellets were re-suspended in 40-70μL of UltraPure water. A 1:10 
dilution was made with UltraPure water and RNA concentration and purity was determined 
using a NanoDrop by measuring absorbance at 260nm and 280nm (A260 and A280 
respectively). A pure RNA sample was indicated by an A280/A260 ratio of 1.8-2.0.  
2.13.3  cDNA Synthesis  
Contaminating DNA in the RNA samples prepared in 2.13.2 was removed prior to 
complementary DNA (cDNA) synthesis as follows. A reaction mixture was prepared in PCR 
tubes, consisting of 6.0μL RNA sample (containing 2μg total RNA made up to volume with 
UltraPure water), 2μL MMLV 5x reaction buffer and 2μL DNase RQ1 (Appendix 2). Samples 
were incubated at 37°C for 30 min in a PCR machine, followed by the addition of 1μL RQ1 
DNase stop solution (Appendix 2), after which samples were incubated for a further 10 min 
at 65°C to inactivate DNase. Oligo dT primer (1 μL) (Appendix 2) was then added and the 
samples were heated for 5 min at 70°C in the PCR machine. The samples were then placed 
immediately on ice. The PCR machine was set at 42°C. A master mix containing the following 
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components was prepared: 3μL MMLV 5x reaction buffer, 5 μL dNTPs 2.5 mM each, 1 μL 
MMLV-RT and 4 μL UltraPure water per reaction. 13 μL of the master mix was added to each 
PCR reaction tube. A control reaction was also prepared using UltraPure water as the 
replacement for MMLV-RT (-RT control). The total reaction volume per sample was 25 μL. 
Samples were then incubated for 1 hour at 42°C after which they were stored at -80°C until 
required for qRT-PCR. 
2.13.4 Quantitation of APH transcripts in the presence and absence of phosphate 
APH transcripts (APH1, APH2, APH3 or APH4) were quantified by qPCR using cDNA 
prepared from WT and ∆aph1-1 (as described in 2.13.3) and SYBR Green real time PCR 
master mix (Life Technologies) on a Rotorgene 6000, 1 Corbett Research qPCR machine. 
*APH1 expression was calculated using the ΔΔCt method using the housekeeping gene, 
actin, (ACT1), for normalization. 
 
 
 
 
 
Table 3. List of primer sequences used for qPCR. (s) indicates sense and (a) antisense   
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3 Results 
3.1 Identification of putative acid phosphatases encoded by the C. neoformans 
genome  
To identify putative acid phosphatases encoded by C. neoformans genome, a BLAST 
search of the C. neoformans Serotype A strain H99 genomic database (CNAG) 
(http://www.broadinstitute.org/annotation/genome/cryptococcus_neoformans/MultiHome
.html) was performed using the protein sequence of the secreted acid phosphatase, Pho5, 
of Saccharomyces cerevisiae as a query. The search found four putative acid phosphatases: 
CNAG_06967, CNAG_02681, CNAG_06115 and CNAG_02944, with homology to Pho5. 
Analysis of the corresponding proteins with the SignalP 4.1 prediction program 
(http://www.cbs.dtu.dk/services/SignalP/) revealed that only CNAG_02944 is predicted to 
be secreted, since it contains a secretion signal peptide at the N-terminus (Figure 3.1).  
From here on, CNAG_02944 will be referred to as APH1. Analysis of the predicted 
amino acid sequence of Aph1 using pfam  
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype
=2&uid=pfam00328) indicates that this protein belongs to branch 2 of the histidine 
phosphatase superfamily.  
 
MRSAALFALLPILANAAAVERRTADSNVGSTTSDVFPPAGTSVNSKLFPAESVVGYPGATVT
GAEPAAAVTAAAYAYNDGTSNSFPLVADQPTGNGSEGFDVFKYWGNLSPWYSVPSSFYGLND
TSPLIPDSCSITQVHLLYRHGARYPTSGAGPSTFAAKLADATAQDGGFTAKGDLDFLNKWTY
KLGAELLTPFGRLQNFELGVTFRQQYGELLNNFTEQGALPVFRTESQDRMVKTAENFAAGFF
GVPEYLDQVSIELMVETSGVNNTGAPYETCPNSNIASRGSLGSTAASSFATDAFNGTVSRLQ
SYINGVEFDTTDVLAMLQLCSYETDALGYSAFCGVFTEEDFKNYEYYFDLNFYYNNGAGSPV
AAAQGKGFLEEFVARFTQTPITSSNSSVNTNLDSNSTYFPLNQSIYADATHEVVLLDTFTAF
NLSALFSTGPLPVDKRAEGSSFVASQVVPFATHMVVQVLECADQTPSKQMRFMINDAVLPLD
KSYEGCGWNKDGMCAFDTVVAALQKRIAEIDYDYDCHGDYTVEAGHDYNGRAPRA 
 
Figure 3.1 Predicted amino acid sequence of Aph1 (CNAG_02944).  
The secretion signal peptide is highlighted in yellow. The histidine phosphatase domain is 
indicated by the blue highlight and was used in the clustering analysis in Figure 3.2.  
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3.2 Protein clustering analysis 
To determine the degree of similarity among cryptococcal acid phosphatases, and between 
cryptococcal acid phosphatases and those produced by other fungal species, a clustering 
analysis was performed using the Phylogeny.fr software (http://www.phylogeny.fr/). Due to 
low sequence similarity among fungal acid phosphatases, only the histidine phosphatase 
domains (see blue highlight in Figure 3.1) were used in the analysis. The results are shown in 
Figure 3.2.  
 
SP+/- indicates presence or absence of the secretion signal peptide. Only the histidine 
phosphatase domains were used in this analysis. Unless otherwise indicated, the accession 
numbers used above are from the NCBI database: Mo, Magnaporthe oryzae; Aniger, 
Aspergillus niger; Anid, Aspergillus nidulans; Sp, Schizosaccharomyces pombe; Ao, 
Aspergillus oryzae; Um, Ustilago maydis;  Fo, Fusarium oxysporum; Tr, Trichophyton rubrum; 
Figure 3.2 Protein clustering analysis based on the alignment of C. neoformans acid 
phosphatases and their homologs  in other fungal species. 
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Ci, Coccidioides immitis; Ca, Candida albicans; CNAG, Cryptococcus neoformans serotype A 
genome (gene IDs from the Broad Institute database), Sc; Saccharomyces cerevisiae (gene 
IDs from the SGD database). SP+/- indicates presence or absence of the secretion signal 
peptide. Only the histidine phosphatase domains were used in this analysis. Bootstrap 
values, which are a measure of the confidence of the branching prediction, are shown in red. 
The position of cryptococcal Aph1 is highlighted by the red frame. 
 
Table 4.  Percentage similarity and identity of the four acid phosphatases encoded in C. 
neoformans genome respective to each other. Predicted protein sequences were used to 
determine the respective percentages. 
CnAPH APH1 APH2 APH3 APH4 
Identity Similarity Identity Similarity Identity Similarity Identity Similarity 
APH1  40.3% 59.5% 24.2% 43.2% 19.5% 32.2% 
APH2 40.3% 59.5%  25.6% 41.2% 22.1% 34.3% 
APH3 24.2% 43.2% 25.6% 41.2%  17.8% 31.0% 
APH4 19.5% 32.2% 22.1% 34.3% 17.8% 31.0%  
 
Clustering analysis indicates that the closest homolog of Aph1 (40.3% identical and 
59.5% similar) is CNAG_06967 (APH2), which is not predicted to be secreted. Both proteins 
are close to phytases (phytic acid-degrading enzymes), MINPP (multiple inositol 
polyphosphate phosphatases) from Aspergillus oryzae and Pho4 from Schizosaccharomyces 
pombe, but not to Pho3/5/11/12 from Saccharomyces cerevisiae. Interestingly, the 
predicted phytase, CNAG_02681 (APH3), clusters with the rest of the phytases from other 
fungal species, while CNAG_06115 (APH4) is the most distantly related to other acid 
phosphatases used in the analysis. Both secreted and intracellular acid phosphatases are 
represented in fungi. For example, all acid phosphatases of S. cerevisiae are secreted, while 
their counterparts in human pathogen Candida albicans are intracellular. Similar to C. 
neoformans, the genome of another basidiomycete, Ustilago maydis, contains both 
secreted and intracellular acid phosphatases.   
40 
 
3.3  Characterization of Aph1 using targeted gene deletion analysis 
APH1 gene deletion: To determine whether Aph1 contributes to the extracellular 
acid phosphatase activity produced by C. neoformans, and to assess its role in cryptococcal 
cellular function, phosphate homeostasis and virulence, the APH1 gene (CNAG_02944) was 
selectively deleted in C. neoformans strain H99 (wild type, WT) as described in section 2.6. 
An APH1 gene deletion construct, containing an antibiotic resistance marker, was created in 
vitro by overlap PCR and introduced into WT C. neoformans using biolistic transformation 
(Figure 3.3). Biolistic DNA delivery, as opposed to heat shock or electroporation, is essential 
to allow the DNA to penetrate the capsule and cell wall. Once inside the nucleus, the 
deletion construct can undergo homologous recombination with the genomic DNA flanking 
APH1, thus replacing the APH1 coding sequence with the resistance marker (Figure 3.3).  
The deletion construct consisting of the neomycin/G418 resistance marker (NEO) regulated 
by the actin promoter (ActP) and Tryptophan terminator (Ttrp) and the 5’ and 3’ flanking 
regions of the APH1 gene, was created in vitro by overlap PCR and introduced into C. 
neoformans by biolistic transformation. Stable G418-resistant recombinants created by 
homologous integration of the deletion construct at the native APH1 gene locus were 
selected on G418 agar plates. Arrows and arrowheads indicate the primer binding sites and 
the dotted lines represent homologous recombination. All primer sequences indicated are 
listed in Section 2.6.2, Table 2. ORF is open reading frame. 
 
  
Figure 3.3 Diagram of the APH1 gene deletion construct (bottom) and the position of its 
integration site in the genome (top).  Note: Figure not to scale. 
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In fungal cells, neomycin resistance cassette provides resistance to the related 
antibiotic, geneticin (G418). Geneticin-resistant transformants were selected by growth on 
G418-containing plates. 96 transformants were then subjected to a preliminary screen to 
identify those that had lost extracellular acid phosphatase activity as a result of successful 
APH1 gene deletion. For this screening, each transformant was grown in a single well of a 96 
well plate, and was supplemented with the chromogenic acid phosphatase substrate, para-
nitrophenolphosphate (pNPP), as described in section 2.7.1. Production of a yellow colour 
following addition of sodium carbonate was indicative of pNPP hydrolysis by the 
transformant and the presence of extracellular acid phosphatase activity. Out of the 96 
transformants screened, 3 did not produce a yellow colour (i.e. the media remained clear) 
and thus did not release active acid phosphatase into the medium (Figure 3.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Each colony was inoculated into phosphate-deficient medium, grown overnight, and then 
incubated with the chromogenic substrate, pNPP, at acidic pH for 20 min at 37°C. The 
reactions were stopped by addition of saturated Na2CO3. Yellow colour indicates the 
production of extracellular acid phosphatase activity. Three out of 96 transformants did not 
produce acid phosphatase activity (media remained clear) and are indicated by red circles. 
 
Genomic DNA was then prepared from these 3 transformants (named #1, #2 and #3) 
as described in section 2.5 and PCR was performed to confirm that integration of the 
deletion construct had occurred at the APH1 gene locus (Sections 2.3 and 2.6). PCR primer 
sets OTS5’/ActP-a and Ttrp-s/OTS3’ were designed to amplify the DNA spanning the 5’ and 
the 3’ integration sites, respectively (Figure 3.3), giving product sizes of 787bp and 952bp, 
respectively. The results in Figure 3.5 show that the expected PCR products were present in 
Figure 3.4  Screening of neomycin-resistant transformants for the production of extracellular 
acid phosphatase activity to identify potential Δaph1 mutants. 
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clones #2 and #3, but not in clone #1, confirming that targeted APH1 deletion had occurred 
in clones #2 and #3 only. A faint band of the correct size was obtained for the PCR of the 3’ 
flanking region of clone #1, which is most likely to be contamination from the adjacent lane, 
and no band was obtained for the PCR of the 5’ flank. As expected, no bands were visible in 
the control PCR where WT was used as a template. 
 
 
 
 
 
 
 
 
 
 
 
 
Genomic DNA was extracted from those transformants that did not secrete active acid 
phosphatase (clones #1 , #2 and #3 in Figure 3.4) and used as a template in PCR with 
primers APH1-OTS5’/ActP-a and Trp-s/APH1-OTS3’(see Figure 3.3 and Table 2.). Only clones 
#2 (which will now be referred to as Δaph1-1) and #3 (which will now be referred to as 
Δaph1-2) had integrated the deletion cassette at the site of the native APH1 locus, as 
indicated by the presence of 2 PCR products of the expected size. These bands were absent 
in the control PCR reaction where WT was used as a template. 
 
3.4 Comparing the production of extracellular acid phosphatase activity by WT and 
Δaph1-1 in low and high phosphate 
In the model yeast S. cerevisiae and in filamentous fungi, a subset of acid 
phosphatases are secreted in response to a low phosphate environment. These extracellular 
acid phosphatases then hydrolyse complex organic phosphate sources to release free 
phosphate (Pi) for uptake via a set of membrane transporters (Figure 1.3). 
To confirm that Aph1 secretion is regulated by phosphate availability, C. 
neoformans WT and Δaph1-1 were incubated in phosphate-deficient (inducing) and 
phosphate-replete (non-inducing) media for 3 hours prior to the addition of the 
Figure 3.5. PCR verification of APH1 gene deletion in transformants with defective acid 
phosphatase secretion. 
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chromogenic substrate, pNPP. Hydrolysis of pNPP by extracellular Aph1 was then measured 
at 5 min intervals over an 80 min time course by taking absorbance readings at 420 nm, the 
wavelength at which the pNP hydrolysis product absorbs maximally. Figure 3.6 
demonstrates that extracellular acid phosphatase activity is only produced by the WT strain 
in the absence of phosphate.  The amount of pNPP hydrolysed by the WT strain increases 
over the time course and reaches plateau at around 40 min. No acid phosphatase was 
secreted by Δaph1-1 in either phosphate deficient or phosphate replete conditions. These 
findings indicate that almost all of the secreted acid phosphatase activity in strain H99 is 
contributed by Aph1 and that similar to Pho5 in S. cerevisiae, Aph1 secretion in C. 
neoformans is regulated by phosphate availability. 
 
 
Figure 3.6 Secreted Aph1 activity assay in WT and aph1-1 under inducing (P-) and non-
inducing (P+) conditions. 
WT and Δaph1-1 were incubated for 3 hours under phosphate replete (MM-KH2PO4: non-
inducing/P+) or phosphate-deficient (MM-KCl: inducing/P-) conditions. The chromogenic acid 
phosphatase substrate, pNPP, was then added to the medium. Hydrolysis of pNPP by 
extracellular acid phosphatase(s) was measured at 5 min intervals over an 80 min time 
course by taking absorbance readings at 420 nm. The results represent the mean and 
standard error of two biological replicates. 
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3.5 Comparing APH1 gene expression in WT and Δaph1-1 in low and high phosphate 
using semi-quantitative real time PCR (qPCR)  
In S. cerevisiae and filamentous fungi, limited phosphate availability causes acid 
phosphatase-encoding genes to be transcribed and translated into protein, which is 
released into the external environment via the secretory pathway. The results in Figure 3.6 
demonstrate that secretion of Aph1 is also phosphate-regulated. In order to determine 
whether Aph1 secretion correlates with APH1 gene expression, the latter was compared in 
WT and Δaph1-1 under inducing and suppressing conditions using qPCR. The results in 
Figure 3.7 demonstrate that expression of APH1 in WT was suppressed in the presence of 
phosphate and induced ~340 fold when phosphate was depleted. As expected, APH1 mRNA 
production was absent in Δaph1-1 under both conditions, confirming that APH1 had been 
deleted.  
 
 
 
 
 
 
 
 
WT and Δaph1-1 were incubated for 3 hours under phosphate-replete (non-inducing) or 
phosphate-deficient (inducing) conditions, as in Figure 3.6. RNA was extracted and cDNA 
synthesized. APH1 transcripts were quantified by qPCR using the ΔΔCt calculation method 
after normalizing against expression of the housekeeping gene actin 1 (ACT1). The results 
represent the mean and standard error of 3 biological replicates. The level of APH1 
expression in the induced WT sample was statistically greater than all other samples 
(p<0.05). 
 
 
Figure 3.7 Comparing APH1 gene expression in WT and Δaph1 in low and high phosphate 
conditions. 
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3.6 Determining the substrate specificity of Aph1 using a Malachite Green Assay 
To identify potential physiological substrates of Aph1, WT and Δaph1-1 were grown 
under phosphate-deficient conditions to induce expression of APH1 and secretion of the 
Aph1 protein, as shown in Figures 3.6 and 3.7, respectively. The ability of culture 
supernatants from induced and non-induced cells to hydrolyze a diverse range of 
phosphorylated macromolecules (amino acids, sugars, nucleotides and lipids) was then 
compared. The phosphate released from each substrate as a result of Aph1-mediated 
hydrolysis was quantified spectrophotometrically using a malachite green assay described in 
2.8 and the results are shown in Figure 3.8.  Culture supernatant from WT, but not from 
∆aph1, readily hydrolyzed the phosphate from the amino acid phosphotyrosine but not from 
phosphothreonine or phosphoserine (Figure 3.8A). The phosphorylated sugars, glucose-1-
phosphate and mannose-6-phosphate, the phosphorylated polyol, β-glycerol phosphate, 
and the nucleotides, adenosine monophosphate (AMP) and adenosine triphosphate (ATP) 
were also found to be good substrates of Aph1 (Figure 3.8A). Since Aph1 clusters with 
phytases produced by other fungal species, IP6 was also tested as a substrate. However, I 
was unable to demonstrate that IP6 was a substrate of Aph1 because the malachite green 
compound reacted with IP6 forming a precipitate. The hydrolysis of two of the preferred 
substrates of Aph1, β-glycerol phosphate (Figure 3.8B) and phosphotyrosine (Figure 3.8C) 
was also measured over a 60 min time course using the malachite green assay. For both 
substrates, a linear increase in phosphate release by WT supernatants, but not by ∆aph1-1 
supernatants, was observed.  
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Figure 3.8 Aph1 catalyses hydrolysis of β-glycerol phosphate, glucose-1-phosphate, 
mannose-6-phosphate, phosphotyrosine, AMP and ATP. 
WT and Δaph1-1 were grown in low phosphate medium overnight to induce APH1 
expression and Aph1 secretion. Secretions were collected as a source of secreted Aph1 
enzyme and incubated with the substrates indicated. The amount of free phosphate 
released from each substrate in 40 min (A) or from two preferred substrates, β-glycerol 
phosphate (B) and phosphotyrosine (C) over a 60 min time course was then quantified using 
the malachite green assay as described in 2.8. Except for ATP (one replicate), all 
experiments were conducted on three biological replicates and error bars indicate standard 
error of the mean. 
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3.7  Impact of APH1 deficiency on fungal growth 
3.7.1 Impact of APH1 deficiency on fungal growth at elevated temperature and in the 
presence of salt and cell wall perturbing agents 
 
The impact of APH1 deficiency on fungal growth at elevated temperature, and in the 
presence of cell wall perturbing agents and high salt concentration was assessed using a 
drop dilution assay (Figure. 3.9). Cell wall stress resistance was tested since extracellular 
Aph1 may play a role in modulating the activity of cell wall proteins via their 
dephosphorylation. The cryptoccocal cell wall is mainly made up of β-(1,3)-D-glucans, β-
(1,4)-D-glucans, β-(1,6)-D-glucans, chitin and glycoproteins, which are involved in its 
synthesis (reviewed in (Doering, 2009)). Congo Red binds to the β-(1,3)-D-glucan chains. 
Calcofluor white (CFW) binds to chitin and SDS is a detergent which denatures proteins in 
the cell wall. Under all of these conditions the phosphate levels were sufficient to support 
growth. ∆aph1-1 grew at a similar rate to WT at 30°C, 37°C and 39°C and in the presence of 
salt (1M NaCl) and cell wall perturbing agents Congo red, SDS and CFW. ∆aph1-1 also grew 
at a similar rate to the WT in the absence of free phosphate (0.5% KCl). The growth test was 
also performed on 0.4% KH2PO4 as a phosphate-replete control and, as expected, the 
growth rate of all strains was similar. Growth in the presence of phytic acid (IP6) as the sole 
source of phosphate was also tested since Aph1 showed close homology to many fungal 
phytases (Figure 3.2). However, the results showed that there was no differences in the 
growth rate of Δaph1-1, Δaph1-2 and WT on IP6.  
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Drops containing the indicated number of cells were plated on the different media and 
incubated for 3 days.  Phosphate replete conditions (0.4% KH2PO4: non Aph1-inducing), 
phosphate-deficient conditions (0.5% KCl: Aph1 inducing). Plates containing just YPD, or YPD 
with NaCl or Congo red or SDS or calcofluor white (CFW), all contained a sufficient source of 
phosphate. Where IP6 was used, it was the sole source of extracellular phosphate. 
 
  
 
Figure 3.9 Comparison of WT, Δaph1-1 and Δaph1-2 growth using a drop dilution assay 
under the conditions indicated. 
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3.7.2 Impact of APH1 deficiency on fungal growth during multiple stresses 
Since C. neoformans experiences multiple stresses when infecting a host, including 
a deficiency in free Pi (Kretschmer et al., 2014), the growth rate of ∆aph1 was compared to 
WT during Pi deprivation combined with one or two additional stresses: high temperature, 
salt or cell wall stress (Congo Red). Cells were also starved of phosphate for 3 hours before 
they were dropped onto phosphate-deficient plates to deplete intracellular polyphosphate 
stores.  However, no differences between the WT and ∆aph1-1 growth rates were observed 
in any condition (Figure 3.10). 
 
Figure 3.10 Comparison of WT and Δaph1-1 growth using a drop dilution assay under the 
conditions indicated. 
Cells were grown in Pi-free media for 3 hours prior to plating, to deplete internal stores of 
polyphosphates. Drops containing the indicated number of cells were plated onto plates 
without phosphate (0.5% KCl: Aph1 inducing) and containing either Congo Red or NaCl.  
Plates were incubated at either 30°C or 37°C for 3 days.  
3.7.3 Impact of APH1 deficiency on fungal growth in the presence of Aph1 substrates as 
the sole phosphate source  
Growth of WT, Δaph1-1 and Δaph1-2 were compared in the presence of β-glycerol-
phosphate or glucose-1-phosphate as the sole source of phosphate in a drop dilution assay. 
β-glycerol phosphate and glucose-1-phosphate are both substrates of Aph1 (Figure 3.8). 
Control plates containing abundant free phosphate and either glycerol or glucose were also 
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employed. However, no differences in growth between the WT and the two Δaph1 strains 
were observed under any condition tested (Figure 3.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drops containing the indicated number of cells were plated onto control plates: phosphate 
replete/0.4% KH2PO4/non Aph1-inducing containing either free glycerol or free glucose, or 
test plates: phosphate-deficient/0.5% KCl/Aph1 inducing) containing β-glycerol-phosphate 
or glucose-1-phosphate as the sole source of phosphate. The plates were then incubated at 
30°C for 3 days. β-glycerol-phosphate and glucose-1-phosphate are both substrates of Aph1 
(Figure 3.8). 
 
3.8 Impact of APH1 deficiency on capsule production. 
Capsule is a major virulence factor of C. neoformans and is anchored to the cell wall. 
Aph1 protein therefore potentially associates with the capsule during its release from the 
cells and may play a role in its production. Capsule production was therefore compared in 
WT (H99) and ∆aph1-1 and using India Ink negative staining and light microscopy as 
described in 2.12 (Figure 3.12). The size of the capsule was then measured in 40 cells form 
each strain and expressed relative to the size of the cell body as described in 2.15.2. 
Figure 3.11 Comparison of WT, Δaph1-1 and Δaph1-2 growth using a drop dilution assay 
under the conditions indicated. 
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However, no statistically-significant difference in the mean capsule: cell body ratio was 
observed: WT - 1.6±0.394 and Δaph1- 1.8±0.126 (p>0.05), with errors representing standard 
deviation. 
 
 
 
 
 
 
 
 
 
3.9 Assessing the role of Aph1 in virulence  
3.9.1 Galleria mellonella model  
The contribution of Aph1 to the virulence of C. neoformans was investigated in a 
survival study using two well accepted animal models of cryptococcosis: the greater wax 
moth, Galleria mellonella, and mice (Mus Musculus). Galleria mellonella larvae were 
inoculated directly into the haemocoel via injection of Cryptococci into the proleg, while 
mice were inoculated by inhalation of Cryptococci to mimic the natural route of infection. To 
determine whether a similar number of viable WT and Δaph1 cells were inoculated (cell 
counts determined by microscopy) each inoculum was plated onto agar and the number of 
CFUs determined after 2-3 days growth at 30°C. The numbers of CFUs obtained for WT, 
Δaph1-1 and Δaph1-2 were within 5% of the microscopy cell counts and within 10% of each 
other. 
The results of the wax moth survival study, where the virulence of WT is compared 
to Δaph1-1 and Δaph1-2, is presented in Figure 3.13. Five infection groups were created and 
observed: uninjected larvae, mock (PBS-injected), WT-infected and Δaph1-1-infected and 
Δaph1-2-infected. Each group contained 10 larvae except for the Δaph1-1-infected group, 
which contained 20 larvae. No larvae died in the uninjected group while 2 died in the mock-
infected group, most likely from physical trauma due to the injection procedure. The median 
survival time of WT-, Δaph1-1- and Δaph1-2-infected larvae was 3, 6 and 5 days, respectively. 
Figure 3.12 Visualisation of the WT and Δaph1-1 capsules by negative staining with India 
Ink and light microscopy at 100x magnification. 
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However, only the median survival of Δaph1-1-infected larvae differed significantly from 
that of WT (P-0.028) (Table 5). This was most likely because more larvae were used.  
Table 5. Median survival day of mice infected with WT, Δaph1-1 and Δaph1-2. P-values are 
also shown. 
 Median survival (days) p- value (compared to WT) 
WT H99 3  
Δaph1-1(n=20) 6 0.028 
Δaph1-2(n=10) 5 0.062 
 
 
Figure 3.13 Survival study in Galleria mellonella. 
Larvae were injected with 1 x 106 fungal cells via the proleg and their viability was assessed 
on a daily basis for 13 days. The graph indicates that the WT-infected larvae (grey line) had a 
lower survival rate compared to Δaph1-1 (black line) and Δaph1-2 (thick light blue line) 
infected larvae. However using a Kaplan Meier log rank test, the difference was only 
statistical significant when compared with Δaph1-1 (p-0.028*) where more larvae were used. 
All of the uninjected larvae and 80% of the PBS-injected controls survived until the 
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experiment was terminated (day 13). ** indicates statistical significance between the un-
injected and PBS-injected controls and both the WT and APH1 mutants.   
 
3.9.2  Murine model of infection 
Galleria mellonella was used as an initial screening tool to test for virulence prior to 
using mice. As statistical significance was achieved using 20 larvae for the Δaph1-1 infection 
group and 10 larvae for the WT infection group, similar numbers of mice were used in the 
murine survival study. Mice were inoculated intranasally as indicated in 2.10.2 and their 
health was monitored over a period of 20 days. Mice showing debilitating symptoms of 
infection were culled and their deaths recorded. Differences in median survival were 
calculated using a Kaplan Meier log rank test, but the difference in median survival of WT-
inoculated larvae (14 days) and Δaph1-1-inoculated larvae (17 days) was not statistically 
significant (p=0.163) (Figure 3.14). However, when a log rank test stratified by species was 
performed using the WT and Δaph1-1 data from the larval and mouse study, this combined 
analysis did demonstrate a statistically significant difference in virulence of WT and Δaph1-1 
(P=0.012) (Figure 3.15). 
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Figure 3.14 Survival study in mice. 
The role of Aph1 in fungal virulence was assessed using a mouse inhalation model. C. 
neoformans WT (n=10) or aph1-1 (n=20) (5 x 105 fungal cells in 20 µl PBS) were inoculated 
intranasally in mice and observed daily for signs of ill-health. Mice which showed respiratory 
distress or which had lost 20% of their pre-infection weight, were deemed to have 
succumbed to the infection and were euthanized. A Kaplan Meier log rank test was then 
performed. However, the difference in median survival was not statistically significant 
(P=0.163).  
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A log rank test stratified by species was performed using WT and Δaph1-1 data from both 
the larval and mouse study (Figure 3.13 and 3.14). This combined analysis performed with 
the assistance of statistician Karen Bythe (Western Sydney Local Health District) 
demonstrated a statistically significant difference between WT and ∆aph1-1 (P=0.012). 
 
3.10  Investigating potential mechanisms of Aph1 contribution to C. neoformans 
virulence: Role of Aph1 in adhesion of Cryptococci to lung epithelium 
Previous studies by (Collopy-Junior et al., 2006) measured the effect of inhibitors of 
acid phosphatase on the attachment of C. neoformans to kidney epithelial cells and 
demonstrated that fungi with irreversibly inhibited acid phosphatase activity are less capable 
of adhering to these cells. A potential problem with this approach is that acid phosphatase 
inhibitors are non-specific. In this section, a more direct approach is used to assess the effect 
Figure 3.15 Combined survival analysis. 
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of secreted Aph1 activity on fungal adherence: by determining the extent of binding of WT 
and ∆aph1-1 to a monolayer of the lung epithelial cell line, A549, using colony counting 
(2.12). The results in Figure 3.16 indicate that there is no significant difference between the 
binding of WT and Δaph1-1 to lung epithelial cells. 
 
Figure 3.16 Attachment of WT and aph1-1 fungal cells to a lung epithelial cell line. 
A549 Cryptococcus strains were grown overnight in MM-KCl (low phosphate, Aph1 inducing 
media). The cells were counted and resuspended in the 2 day-old (spent) A549 cell culture 
medium rather than fresh medium to ensure that phosphate levels remain depleted and, 
hence, secreted Aph1 levels high. After co-incubation of C. neoformans and A549 cells, the 
unbound fungal cells were removed. The number of fungal cells that remained attached was 
determined by lysing the epithelial monolayer and plating the cryptococcal cells onto SAB 
plates, followed by counting of the colonies formed after 2 days incubation at 30°C. The 
results represent the mean and standard error of 3 biological replicates. This experiment 
was performed with the assistance of Dr Sophie Lev. 
 
3.11 Determining whether the expression of APH2, APH3 and APH4 is phosphate-
regulated and dependent on APH1 
To determine whether the expression of APH2, APH3 and APH4 are also regulated 
by phosphate availability, the level of expression of each gene was compared in WT in the 
presence and absence of phosphate (Figure 3.17). In the absence of phosphate, the 
58 
 
expression of APH2, APH3 and APH4 increased, although not as considerably by 2.844-fold, 
21.1-fold and 228.31-fold, respectively, compared to ~330 fold for APH1 (Figure 3.7), 
confirming that expression of APH3 and APH4, and to a much lesser extent APH2, is 
regulated by phosphate availability. Since Aph1 has a minor contribution to virulence in two 
animal models (Figure 13-15), it was hypothesized that, if functional redundancy exists 
among the APH family, expression of some/all acid phosphatase-encoding genes would 
increase above WT levels in the absence of Aph1 as a potential mechanism of compensation. 
To test this hypothesis, expression of APH2, APH3 and APH4 was tested in the ∆aph1-1 
strain following incubation in Pi-deficient and Pi-replete media (Figure 3.17). While the 
expression of APH3 and APH4 and, to a lesser extent of APH2, was induced in Δaph1-1 in the 
absence of Pi, it was not higher than in the WT strain.  
 Continued on page 59 
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WT and Δaph1-1 were incubated for 3 hours under Pi-replete (non-inducing) or Pi-deficient 
(inducing) conditions, as in Figure 3.6. RNA was extracted and cDNA synthesized. APH2,3,4 
transcripts were quantified by qPCR using the ΔΔCt calculation method after normalizing 
against expression of the housekeeping gene actin 1 (ACT1). The experiment was conducted 
in 3 biological replicates with error bars indicating standard error. *Indicates that the 
increase in expression is statistically significant relative to all other samples (p<0.05). ** 
indicates that the increase in expression is statistically significant, relative to its non-induced 
control only, as determined  using one-way ANOVA with a Tukey post-hoc test. Primer pairs 
used are indicated in section 2.13.4, Table 3. 
  
Figure 3.17 Expression of APH2, APH3 and APH4 in the presence and absence of 
phosphate in WT and aph1-1 strains. 
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4  Discussion 
Extracellular acid phosphatase activity has been detected in a large proportion of C. 
neoformans strains isolated from patients with AIDS (Vidotto et al., 2006), suggesting that 
the enzyme(s) responsible play a role in cryptococcal virulence. The secreted acid 
phosphatase in the model non-pathogenic yeast, Saccharomyces cerevisiae, is Pho5, which 
contains a secretory leader peptide and is a component of the phosphate responsive (PHO) 
system (Figure 1.3). A major aim of this thesis was to identify the enzyme(s) responsible for 
extracellular acid phosphatase activity in the clinical Cryptococcus neoformans serotype A 
type strain, H99. A BLAST search of the C. neoformans database using the Pho5 protein 
sequence as a query identified four putative acid phosphatases, with only CNAG_02944 
(Aph1) predicted to be secreted on the basis of the presence of a signal peptide (SP). 
Interestingly, the other acid phosphatases CNAG_06967 (Aph2) CNAG_02681 (Aph3) and 
CNAG_06115 (Aph4) do not contain a signal peptide and are therefore most likely to be 
intracellular. In support of this, our research group only identified Aph1 in a proteomic 
analysis of the H99 secretome (Lev et al., 2014).  
 
4.1  Phylogenetic analysis of fungal acid phosphatases 
Phylogenetic analysis of fungal acid phosphatases demonstrates that Aph1 is most 
similar to Aph2 (59.5% similar, 40.3% identical) suggesting that one arose from the other by 
gene duplication. Gene duplication plays a key role in an organism’s complexity, adaptation 
and diversification to closely related strains and species (Prince & Pickett, 2002) (Long et al., 
2003). It is also interesting to note that, similar to other fungal species, the cryptococcal acid 
phosphatase group includes extra- and intracellular members, indicating that these enzymes 
have functions both inside and outside the cell. The secreted acid phosphatase, Pho5, in S. 
cerevisiae shares 51.6% similarity and 19.86% identity with Aph1. Aph1 did not cluster with 
Pho5 in S.cerevisiae, even though it was found to be regulated in the same way. 
Interestingly cryptococcal acid phosphatases are relatively close to phytases from other 
fungal species, suggesting that IP6 is a substrate and that acid phosphatases might play a 
role in inositol polyphosphate homeostasis. However, IP6 was unable to be shown that it 
was a substrate of Aph1 as the malachite green assay reagent reacted with IP6, forming a 
precipitate.  
61 
 
The other interesting observation from the cluster analysis is that only two of the 
cryptococcal acid phosphatases, Aph1 and Aph2, cluster together. This was despite the fact 
that APH2 induction was not as phosphate-responsive as induction of the other APH genes 
(Figure 3.17). The result suggests that APH1 and APH2 may be less similar in their promoters 
than in their protein coding region. Possible reasons for the divergence of Aph1/Aph2 from 
Aph3 and Aph4 may be that they have evolved to have different roles and/or substrate 
specificities. Determining the substrate specificities of Aph2-4 in future studies will provide 
important information on the function of these enzymes. Clues about functional divergence 
can also be gained by comparing the subcellular location of each APH enzyme and whether 
any of the genes encoding the intracellular APH enzymes are upregulated in the absence of 
Aph1 (see below). Subcellular location has already been determined for Aph1 by attaching it 
to the DsRed fluorophor. Interestingly, it was shown that Aph1 is transported to vacuoles 
and to the cell periphery via endosomes (Lev et al., 2014). Aph1 therefore appears to have 
an intracellular and an extracellular role. The fact that C. neoformans produces many 
intracellular acid phosphatases suggests that they play important roles inside the cell, and 
that some functional redundancy might occur.  
 
4.2 Aph1 production is regulated by phosphate availability and serves as a reporter for 
defining the PHO regulatory system in C. neoformans 
After identifying that Aph1 is the only acid phosphatase in C. neoformans predicted 
to be secreted, the APH1 gene was deleted using a targeted gene deletion strategy. 
Screening for genuine knockout strains was facilitated by the use of a colorimetric enzyme 
assay utilizing pNPP, which is converted to pNP by acid phosphatase. The screen identified 3 
potential knockout clones, only two of which were certified to be genuine knockouts by PCR 
screening (aph1-1 and aph1-2).  
To address aims 2 and 3, the extracellular acid phosphatase activity produced by the 
WT and ∆aph1 strains in the presence and absence of phosphate was compared using the 
same colorimetric assay used in the knockout screening procedure. Acid phosphate activity 
was only detected in WT secretions in the absence of phosphate, but not in Δaph1 
secretions, proving that Aph1 is the sole acid phosphatase contributing to extracellular 
phosphatase activity and that its secretion is regulated by phosphate availability. Using qPCR, 
the regulation of secretion of Aph1 activity in a phosphate-depleted environment was 
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confirmed to occur at the level of transcription. Thus, even though Aph1 did not cluster 
closely to Pho5, which is also induced by phosphate deprivation, the results are consistent 
with Aph1 being the orthologue of Pho5, as the two proteins share a similar mode of 
regulation. Three high-affinity phosphate-repressible phosphate transporters (PHO 89, 840 
and 84) have been identified in C. neoformans (Kretschmer et al., 2014) that could 
potentially allow the free phosphate generated by Aph1 to be incorporated into the cell to 
maintain the high levels required for normal intracellular function. These cryptococcal 
phosphate transporters are orthologues of Pho89 and Pho84 in S. cerevisiae.  
In addition to the high-affinity phosphate transporters, (Kretschmer et al., 2014) also 
identified other probable regulatory components of the PHO system in C. neoformans based 
on their homology to PHO system components in S. cerevisiae, including the cyclin 
dependent kinase Pho85, the cyclin Pho80 and the cyclin-dependent kinase inhibitor Pho81: 
encoded by CNAG_07871, CNAG_01922 and CNAG_02541, respectively. Following 
activation by the Pho85-Pho80-Pho81 complex in S. cerevisiae, transcription factors Pho4 
and Pho2 regulate expression of PHO genes involved in phosphate acquisition and storage 
(acid phosphatases, phosphate transporters and enzymes involved in the synthesis and 
degradation of polyphosphate). However the transcription factor equivalent(s) in C. 
neoformans remain to be identified. Since Aph1 can be used a reporter enzyme for 
activation of the poorly described PHO pathway in C. neoformans, detection of its activity 
using the chromogenic assay described in this thesis will allow the identification of PHO 
translational machinery in future studies using transcription factor knockout libraries.  
 
4.3  Aph1 is not essential for growth of C. neoformans in the absence of an external 
source of phosphate  
In addition to mobilizing phosphate from extracellular organic sources, Aph1 is likely 
to play a role in mobilizing intracellular phosphate from polyphosphate or disposable 
phosphoproteins with expired half-lives, as it has a dominant location in vacuoles (Lev et al., 
2014). The vacuoles of fungal and plant cells are analogous to the lysosomes of mammalian 
cells and are involved in the storage of waste products, and phosphate as polyphosphate. 
Old proteins and other molecules are also broken down and recycled inside vacuoles. Thus 
the location of Aph1 in vacuoles and its ability to remove phosphate from a diverse array of 
molecules sent there for storage (in the case of polyphosphate) or breakdown and recycling 
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(in the case of phosphorylated and carbohydrate-modified proteins) suggests that Aph1 
plays a role in fungal cellular phosphate homeostasis. Vacuoles are acidic and therefore 
provide a favourable environment for Aph1 to function. It would be interesting in future 
studies to determine whether polyphosphate is a substrate of Aph1 as this would provide 
evidence of a role for Aph1 in the release of phosphate from these vacuolar stores.  
The growth rate of WT and ∆aph1 in the absence of phosphate was compared using a 
drop dilution assay (Figure 3.10). ∆aph1 grew at a similar rate to WT in the absence of 
phosphate, where growth of both strains is dependent on phosphate derived from 
intracellular stores such as vacuolar polyphosphates, phospholipids and nucleic acids,  and 
organic phosphate sources such as phosphotyrosine, glucose-1-phosphate, mannose-6-
phosphate, β-glycerol phosphate, AMP and ATP, which are substrates of Aph1 (Figure 3.8). 
This result suggests that intracellular Aph1 is not crucial for the ability of C. neoformans to 
mobilise Pi from intracellular phosphate sources to maintain phosphate homeostasis and 
support cryptococcal growth in an environment depleted of free phosphate.  The putative 
role for intracellular Aph1 in phosphate mobilisation may not be essential for growth of C. 
neoformans in phosphate-deficient medium because the other APHs fullfill the role. 
Intracellular Aph3 and Aph4, and to a lesser extent Aph2, could potentially play a role in 
mobilising Pi from organic sources in the absence of Aph1. Phospholipids constitute a large 
proportion of cellular Pi, and bacteria, plants and some non-pathogenic fungi, such as S. 
cerevisiae and Neurospora crassa, have acquired the ability to replace phospholipids with 
non-phosphorous lipids when Pi is limited (Nakamura, 2013) (Benning et al., 1995) (Lopez-
Lara et al., 2005) (Benning & Ohta, 2005) (Hartel et al., 2000). The ability to form Pi-free 
lipids allows the freeing-up of Pi needed for growth and the maintenance of cellular Pi 
homeostasis. Cryptococcal genes encoding enzymes involved in releasing Pi from 
phospholipids will be tested for Pi responsiveness in future studies. 
The growth rate of WT and ∆aph1 in the presence of the Aph1 substrates, β-
glycerolphosphate or glucose-1-phosphate (Figure 3.8) as the sole source of phosphate, was 
also tested. Surprisingly, ∆aph1 grew at a similar rate to WT in the presence of two Aph1 
substrates, β-glycerol phosphate or glucose-1-phosphate, provided as the sole source of 
phosphate. The ability of secreted Aph1 to make free phosphate available from these 
external organic sources therefore does not appear to be crucial to maintain phosphate 
homeostasis and support cryptococcal growth under these conditions. It is possible that in 
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the absence of secreted Aph1, β-glycerol phosphate and glucose-1-phosphate are 
transported into the cell for hydrolysis by intracellular APHs, or incorporation into cellular 
metabolism.   
 
4.4 Aph1 hydrolyses a diverse range of substrates  
An important functional characteristic of an enzyme is its substrate specificity. 
Depending on the range and type of substrate it is able to catalyse, assumptions can be 
made about its biological and physiological significance. Acid phosphatases are known to 
catalyse a wide range of substrates (Anand & Srivastava, 2012). So the next aim of the thesis 
was to determine the substrate specificity of Aph1. Aph1 was also found to hydrolyse a 
diverse range of substrates including sugars such as glucose-1-phosphate and mannose-6-
phosphate, the lipid precursor β-glycerol phosphate, and the nucleotides adenosine 
triphosphate (ATP) and adenosine monophosphate (AMP), which are important for energy 
production, signaling and modulating the immune response. The results demonstrate that 
Aph1 can scavenge Pi from a wide range of organic phosphates. The only evidence of 
discriminatory hydrolysis of phosphate was among the amino acids. Aph1 demonstrated a 
strong preference for phosphotyrosine, but not for phosphothreonine or phosphoserine. 
Phosphotyrosine is likely to be present on proteins targeted to vacuoles for turnover and on 
signalling molecules. Similar to the nucleotides and sugars, tyrosine contains a bulky 
aromatic side chain whilst serine and threonine contain shorter aliphatic chains terminating 
with an alcohol (Figure 4.1). Except for β-glycerol phosphate, Aph1 displayed a preference 
for bulky aromatic side chains attached to phosphate. The finding in this thesis that 
phosphotyrosine is the preferred amino acid substrate for Aph1 is in contrast to the findings 
of (Collopy-Junior et al., 2006) who found that phosphothreonine was the best substrate of 
the extracellular acid phosphatase activity produced by C. neoformans, which we now know 
from this study is due to Aph1. A possible reason for the different result is that Collopy-
Junior et al used sodium orthovanadate to inhibit extracellular acid phosphatase activity 
whereas in this study Aph1 was eliminated directly through gene deletion. Sodium 
orthovanadate is a non-specific irreversible inhibitor of acid phosphatase activity and may 
therefore have inhibited other important regulatory enzymes such as alkaline phosphatases. 
However, Collopy-Junior did show that -glycerol phosphate is a potential substrate of acid 
phosphatase, and it was confirmed in this thesis that -glycerol phosphate is indeed a  
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substrate of Aph1.  
 
 
 
 
 
 
 
4.5 How does Aph1 contribute to the virulence of C. neoformans?  
Aph1 was not essential for production of key virulence factors, cell wall integrity, 
growth at host temperature (37°C) or stress resistance (Figure 3.9). It was also not essential 
for growth under a combination of stresses (Figure 3.10). However, it was required for full 
virulence in animal models (Figure 3.13-3.15). A previous study by (Collopy-Junior et al., 
All of the above were confirmed to be substrates of Aph1 except phosphoserine, 
phosphothreonine and phytic acid. Except for -glycerol phosphate, Aph1 showed a 
strong preference for a bulky aromatic side chains attached to phosphate. Phytic acid 
(IP6), which is also a bulky aromatic substrate, could not be tested in this thesis because 
the malachite green assay was not compatible.  All structures were obtained from 
http://www.chemicalize.org/.  
 
Figure 4.1 Chemical structure of the potential and confirmed Aph1 substrates. 
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2006) demonstrated that adhesion of C. neoformans cells to an MA104 monkey kidney 
epithelial cell line was reduced following non-specific irreversible inhibition of acid 
phosphatase activity by sodium orthovanadate. Thus, the ability of WT and ∆aph1 to bind to 
a lung epithelial cell line was investigated. However, no difference in binding was found 
suggesting that Aph1 does not promote interaction of C. neoformans with host lung 
epithelium. A possible reason for the discrepancy between these results and those of  
(Collopy-Junior et al., 2006) is that, as mentioned above, sodium orthovanadate also inhibits 
other important regulatory enzymes in addition to Aph1, such as protein tyrosine 
phosphatases and alkaline phosphatases, which may promote fungal adherence in these 
studies. However it cannot be ruled out that another reason for the discrepancy in the 
results is that Collopy-Junior et al used a different cell line.  
Kretschmer et al., 2014 showed that the loss of the high-affinity phosphate 
transporter system in C. neoformans via gene deletion attenuated the expression of the key 
virulence factors capsule and melanin, increased the susceptibility of C. neoformans to 
phosphate starvation and macrophage killing and attenuated the virulence of C. neoformans 
in a mouse model. (Fan et al., 2005) demonstrated that the expression of high-affinity 
phosphate transporter was upregulated during macrophage infection with C. neoformans. 
Taken together, these studies demonstrate that the acquisition of phosphate from the host 
environment is essential for the virulence of C. neoformans. Our findings suggest that Aph1 
is not required for the mobilization of phosphate from host-derived organic compounds to 
the extent that it impacts on growth and Pi homeostasis. However, the possibility cannot be 
ruled out that Aph1 hydrolyses a host-specific substrate other than glucose 1-phosphate or 
-glycerol phosphate which is essential for achieving full virulence.  
 
4.5.1 Host invasion C. neoformans, and most other fungi, play a major role in the 
breakdown of organic matter in the environment by secreting a diverse array of hydrolytic 
enzymes, including proteases, phospholipases and acid phosphatases. Some of these 
enzymes, including phospholipase B (PLB) and proteases are also secreted into the host to 
aid the invasion and dissemination of C. neoformans. Extracellular Aph1 may therefore play 
a role in allowing C. neoformans to invade host tissue potentially by modulating the surface 
of host cells via its dephosphorylation capability (Kiffer-Moreira et al., 2007a), (Kneipp et al., 
2003, Kneipp et al., 2004) (Kneipp et al., 2012) (Fernanado et al., 1999). However, since 
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Aph1, does not affect the binding of C. neoformans to a lung epthithelial cell line, it is 
unlikely that it plays a major role in aiding fungal invasion of the host. In the more advanced 
stages of infection, C. neoformans often forms cryptococcomas in lung and brain tissue, 
which are solid tumor-like masses, or granulomas which are clumps of cells embedded in a 
capsular matrix similar to a biofilm and surrounded by infiltrating monocytes. It has been 
demonstrated that the central regions of cryptococcomas are acidic and therefore provide a 
favorable environment for acid phosphatases to function. 
 
4.5.2 Scavenging phosphate from the host environment One host environment that C. 
neoformans commonly encounters is the inside of the phagolysosome of macrophages, 
since these immune cells are able to phagocytose fungal cells (Geunes-Boyer et al., 2009). 
There is evidence to suggest that the phagolysosome is low in free phosphate since the high 
affinity phosphate system is upregulated in C. neoformans cells during contact with 
macrophages (Fan et al., 2005). Mannose-6-phosphate, which was found to be a substrate 
of Aph1, serves as a recognition marker for targeting mammalian proteins to the lysosome 
and may provide a source of phosphate to C. neoformans growing inside macrophage 
phagolysosomes.   
 
4.5.3 Modulation of the host immune system AMP and ATP were also found to be Aph1 
substrates. Excessive adenosine generation by cryptococcal acid phosphatases may allow 
them to subvert the host immune system. C. neoformans could encounter host-derived ATP 
and AMP when infecting phagocytes or when growing extracellularly. In mammals 
extracellular adenosine generates a cascade of tissue responses (Hasko et al., 2007) (Hasko 
& Pacher, 2012). Studies conducted in human and murine models confirmed that adenosine 
suppresses TNF-α production by monocytes and macrophages (Hasko et al., 2007). 
Pathogens such as Staphylococcus aureus, Enteropathogenic Escherichia 
coli  and  Trichomonas vaginalis  possess surface ectonucleotidases that can cleave the 
phosphate off ATP, ADP and AMP, generating adenosine, providing a means for the 
pathogens to subvert the host immune system. In the same way the ability for C. 
neoformans to utilise AMP and ATP as Aph1 substrates may assist the fungus to thrive in the 
host by impeding macrophage and monocyte function.  
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4.5.4 Signalling The most predominant phosphorylation sites in eukaryotes occur on serine, 
threonine and tyrosine residues (Gomes et al., 2011) and phosphorylation and 
dephosphorylation at these sites is part of a cell’s signalling network. Since Aph1 
preferentially removes phosphate from tyrosine, it may play a role in modulating 
phosphotyrosine-dependent signalling pathways in the fungus as well as the host.   
 
4.6 APH3 and APH4 are induced by Pi deprivation in WT but not to a greater extent in 
the absence of APH1. 
The cluster analysis suggests that Aph1 and Aph2 are closely related and, therefore, 
could have overlapping functions that result in only a small reduction in virulence when one 
enzyme is missing. To determine whether all cryptococcal APH genes are induced by low 
phosphate and whether they may have overlapping functions, the expression of APH2, 
APH3 and APH4 in the presence and absence of phosphate was assessed by qPCR in WT and 
∆aph1. APH3 and APH4, but not APH2, were highly induced in both WT and ∆aph1 during 
phosphate deprivation. However the level of induction of each enzyme in ∆aph1 did not 
exceed that of WT. Since APH2 is expressed regardless of the phosphate status of the cell, it 
could still potentially compensate for the absence of APH1 by mobilizing Pi from 
intracellular sources, even if its level of expression is not elevated in the absence of Aph1. 
Alternatively, other genes and regulators within the PHO system may be responsible for 
mobilizing Pi and compensating for the absence of Aph1. Determining whether the APH 
enzymes have overlapping roles will require deletion of APH2, APH3 and APH4, individually 
and in combination, and assessing the effect of these combination deletions on the 
virulence of C. neoformans in future studies.  
 
4.7 Concluding remarks 
In conclusion, Aph1 was found to be the major secreted acid phosphatase 
responsible for the extracellular acid phosphatase activity in the H99 strain isolated from a 
patient with AIDS. Aph1 production was found to be phosphate repressible at the level of 
APH1 transcription. Aph1 was only found to play a minor role in the virulence of C. 
neoformans, which may be due to compensation from other APH enzymes and/or other 
unidentified gene products of the PHO system. If other APH enzymes compensate for the 
absence of Aph1, this compensation is not reflected by an increase in their gene 
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transcription. The way in which Aph1 contributes to the virulence of C. neoformans is most 
likely via its ability to release Pi from a broad range of physiological substrates, including 
potential immunomodulators, and to contribute to the maintenance of Pi homeostasis.  
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5 Appendices  
Appendix 1  
 
 
 
 
 
 
 
 
 
 
Media and buffers recipe Media/buffers  Recipe  
Minimal medium w/o glucose (laccase 
inducing medium)  
10μM CuSO4, 10mM MgSO4.7H20, 29.4mM 
KH2PO4, 13mM glycine, 3.0μM thiamine-
HCl  
Minimal medium with glucose (laccase 
suppressing medium)  
15mM glucose, 10mM  MgSO4.7H2O , 
29.4mM  KH2PO4, 13mM glycine, 3.0μM 
thiamine-HCl  
Minimal medium w/o phosphate (APH 
inducing medium)  
0.5% KCl, 15mM glucose, 10mM  
MgSO4.7H2O , 13mM glycine, 3.0μM 
thiamine-HCl  
Minimal medium with phosphate (APH 
suppressing medium)  
0.5%  KH2PO4, 15mM glucose, 10mM  
MgSO4.7H2O , 13mM glycine, 3.0μM 
thiamine-HCl  
RPMI-1640 agar   
 
10.4g/L RPMI-1640 reagent, 34.53g/L 
MOPS buffer, 18g/L glucose (pH 7.0). 0.3g/L 
L-glutamine, 15g/L bacto agar 
TBS, 20X  1540mM Tris base, 2.8M NaCl, 540mM KCl 
(pH 8.0)  
Tris-glycine transfer buffer  25 mM Tris base, 192 mM glycine, 20% 
methanol  
YPD agar  50g/L YPD, 2% (w/v) bacto agar  
YPD broth  50g/L YPD  
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Appendix 2  
Manufacturers and 
suppliers of kits, 
chemicals, enzymes, 
and antibodies 
Product  
Product number  Manufacturer  Australian 
distributor  
100% Ethanol  9326410009756  Chem-Supply Pty Ltd, 
SA, AUS  
VWR International, 
QLD, AUS  
1 kb DNA ladder Invitrogen 
Corporation, CA, 
USA Invitrogen Australia 
Pty. 
Agarose Amresco 
Inc., OH, USA 
Astral Scientific, 
NSW, 
AUS  
Acetic acid  100015N  BDH Laboratory 
Supplies, NSW, AUS  
VWR International, 
QLD, AUS  
Acetone  9326410008384  Chem-Supply Pty Ltd, 
SA, AUS  
VWR International, 
QLD, AUS  
Amersham 
hyperfilm™ ECL  
28-9068-35  GE Healthcare Ltd, 
UK  
VWR International, 
QLD, AUS  
Bacto™ agar  281210  Becton, Dickinson 
and Company, MD, 
USA  
Becton, Dickinson 
and Company, NSW, 
AUS  
Bacto™ Yeast Extract  212750  Becton, Dickinson 
and Company, MD, 
USA  
Becton, Dickinson 
and Company, NSW, 
AUS  
Bovine serum 
albumin (BSA)  
-  Moregate Biotech, 
QLD, AUS  
Moregate Biotech, 
QLD, AUS  
Calcofluor-White 
(Fluorescent 
Brightener 28)  
F3543  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Chloroform  1024452500  Merck KGaA, 
Germany  
VWR International, 
QLD, AUS  
Congo Red  C6767  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Copper II sulfate 
(CuSO4.5H20)  
171-500G  Ajax Finechem, NSW, 
AUS  
VWR International, 
QLD, AUS  
dNTPs (2.5mM each)  4030  TaKaRa Bio Company  Scientifix Pty. Ltd., 
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VIC, AUS 
Glass beads, acid 
washed  
G8772-500G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Glucose (Anhyd)  14535 5LB  Affymetrix, Inc., OH, 
USA  
In Vitro 
Technologies, VIC, 
AUS  
Glycerol  0854-1L  Amresco Inc., OH, 
USA  
Astral Scientific Pty, 
Ltd, NSW, AUS  
Glycine  0167-1KG  Amresco Inc., OH, 
USA  
Astral Scientific Pty, 
Ltd, NSW, AUS  
Gold bead. 0.6 μm   Bio-Rad, NSW, AUS   
Hydrochloric acid 
(HCl) 36%  
1367-500ML  Ajax Finechem, NSW, 
AUS  
VWR International, 
QLD, AUS  
Immobilon-P 0.45 
μm transfer 
membrane (PVDF 
membrane)  
IPVH00010  Millipore 
Corporation, MA, 
USA  
Merck Millipore AUS 
Pty. Ltd., NSW, AUS  
India Ink stain  261194  Becton, Dickinson 
and Company, MD, 
USA  
Becton, Dickinson 
and Company, NSW, 
AUS  
Isopropyl alcohol/2-
propanol  
I9516-500ML  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Magnesium sulfate 
(MgSO4.7H2O)  
10151  Merck Pty Ltd., VIC, 
AUS  
Merck Pty Ltd., VIC, 
AUS  
Methanol  M/4056/PB17  Fisher Scientific UK 
Ltd, UK  
VWR International, 
QLD, AUS  
Millex® 0.22μM filter  SLGP033RS  Millipore 
Corporation, MA, 
USA  
Merck Pty. Ltd, VIC, 
AUS  
M-MLV 5x Reaction 
Buffer  
M531A  Promega 
Corporation, WI, USA  
Promega 
Corporation, NSW, 
AUS  
M-MLV RT  M170B  Promega 
Corporation, WI, USA  
Promega 
Corporation, NSW, 
AUS  
NuPAGE® 4-12% Bis-
Tris Gel, 1.0mm, 12 
well  
NP0322BOX  Life Technologies 
Corporation, CA, USA  
Life Technologies 
Corporation, VIC, 
AUS  
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Sample Buffer (4x) - Corporation, CA, USA Corporation, CA, USA 
Oligo (dT) (100μM) 
Primer  
-  Integrated 
Technologies Inc., IA, 
USA  
Integrated 
Technologies Inc., IA, 
USA  
Peptone 
Bacteriological  
LP0037  Oxoid Ltd, England, 
UK  
Thermo Fisher 
Scientific, VIC, AUS  
Phenol red  6614  Hopkin and Williams 
Ltd, England, UK  
-  
Platinum® SYBR® 
Green qPCR 
SuperMix-UDG  
11733-046  Life Technologies 
Corporation, CA, USA  
Thermo Fisher 
Scientific, VIC, AUS  
Ponceau  P3504-10G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Potassium chloride 
(KCl)  
P9333-500G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Potassium 
dihydrogen ortho-
phosphate (KH2PO4)  
391-500G  Ajax Finechem, NSW, 
AUS  
VWR International, 
QLD, AUS  
RPMI-1640 Medium  R7755-10L  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
RQ1 DNase Stop 
Solution  
M199A  Promega 
Corporation, WI, USA  
Promega 
Corporation, NSW, 
AUS  
RQ1 RNase-Free 
DNase  
M610A  Promega 
Corporation, WI, USA  
Promega 
Corporation, NSW, 
AUS  
Promega kit Spin 
Miniprep Kit 
 
 Promega 
Corporation, WI, USA  
Promega 
Corporation, NSW, 
AUS  
Sabouraud Dextrose 
(SAB) agar plates 
-  Media Room, CIDM, 
ICPMR, Westmead 
Hospital, Westmead 
Sodium acetate 
(Anhyd)  
679-500G  Ajax Finechem, NSW, 
AUS  
VWR International, 
QLD, AUS  
Sodium carbonate 
(Na2CO3)  
463-500G  Ajax Finechem, NSW, 
AUS  
VWR International, 
QLD, AUS  
Sodium chloride 
(NaCl)  
102414J  BDH Laboratory 
Supplies, NSW, AUS  
VWR International, 
QLD, AUS  
Sodium dodecyl 
sulfate (SDS)  
0227-1KG  Amresco Inc., OH, 
USA  
Astral Scientific Pty, 
Ltd, NSW, AUS  
Sodium hydoxide 
(NaOH)  
S5881-500G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Sodium phosphate 
dibasic (Na2HPO4)  
S7907  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Sodium phosphate 
monobasic monohydrate 
S9638  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
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(NaH2PO4.H20) 
SYBR Safe DNA gel 
stain 
(10,000 e DNA gel  Invitrogen 
Corporation, CA, 
USA 
Invitrogen Australia 
Pty. 
Ltd., VIC, AUS Sorbitol Sigma-Aldrich, MO, 
USA 
Sigma-Aldrich Pty. 
Ltd., 
NSW, AUS SuperScript III First-
Strand 
Synthesis System for 
RTPCR 
Ex Taq polymerase  Takara Bio Inc., 
Japan 
Scientifix, VIC, AUS 
Thiamine 
Hydrochloride  
T4625-5G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Trichloroacetic acid  T6399-500G  Sigma-Aldrich, MO, 
USA  
Sigma-Aldrich, NSW, 
AUS  
Tris base  0497-1KG  Amresco Inc., OH, 
USA  
Astral Scientific Pty, 
Ltd, NSW, AUS  
Tris-borate-EDTA 
(TBE) 
 Sigma-Aldrich, MO, 
USA 
Sigma-Aldrich Pty. 
Ltd., NSW, AUS 
TRIZOL® Reagent  15596026  Life Technologies 
Corporation, CA, USA  
Life Technologies 
Corporation, VIC, 
AUS  
UltraPure™  10977-023  Life Technologies  Life Technologies  
 
DNase/RNase-Free 
Distilled Water  
Corporation, CA, 
USA  
Corporation, VIC, AUS  
Yeast Extract 
Peptone Dextrose 
(YPD) Broth  
75858  Affymetrix, Inc., OH, 
USA  
In Vitro 
Technologies, VIC, 
AUS  
 
 
 
 
 
  
75 
 
6 Reference 
Alspaugh, J.A., L.M. Cavallo, J.R. Perfect & J. Heitman, (2000) RAS1 regulates filamentation, 
mating and growth at high temperature of Cryptococcus neoformans. Molecular 
microbiology 36: 352-365. 
Anand, A. & P.K. Srivastava, (2012) A molecular description of acid phosphatase. Applied 
biochemistry and biotechnology 167: 2174-2197. 
Arnold, W.N., L.C. Mann, K.H. Sakai, R.G. Garrison & P.D. Coleman, (1986) Acid phosphatases 
of Sporothrix schenckii. Journal of general microbiology 132: 3421-3432. 
Baddley, J.W., D.C. Schain, A.A. Gupte, S.A. Lodhi, L.K. Kayler, J.P. Frade, S.R. Lockhart, T. 
Chiller, J.S. Bynon, Jr. & W.A. Bower, (2011) Transmission of Cryptococcus 
neoformans by Organ Transplantation. Clinical infectious diseases : an official 
publication of the Infectious Diseases Society of America 52: e94-98. 
Belanger, P.H., D.A. Johnston, R.A. Fratti, M. Zhang & S.G. Filler, (2002) Endocytosis of 
Candida albicans by vascular endothelial cells is associated with tyrosine 
phosphorylation of specific host cell proteins. Cellular microbiology 4: 805-812. 
Benning, C., Z.H. Huang & D.A. Gage, (1995) Accumulation of a novel glycolipid and a 
betaine lipid in cells of Rhodobacter sphaeroides grown under phosphate limitation. 
Archives of biochemistry and biophysics 317: 103-111. 
Benning, C. & H. Ohta, (2005) Three enzyme systems for galactoglycerolipid biosynthesis are 
coordinately regulated in plants. The Journal of biological chemistry 280: 2397-2400. 
Bernard, M., I. Mouyna, G. Dubreucq, J.P. Debeaupuis, T. Fontaine, C. Vorgias, C. Fuglsang & 
J.P. Latge, (2002) Characterization of a cell-wall acid phosphatase (PhoAp) in 
Aspergillus fumigatus. Microbiology 148: 2819-2829. 
Casadevall, A., A.L 
. Rosas & J.D. Nosanchuk, (2000) Melanin and virulence in Cryptococcus neoformans. 
Current opinion in microbiology 3: 354-358. 
Casadevall, A.J.R.P., (1998) Cryptococcus neoformans. ASM Press, Washington, DC. 
Chau, T.T., N.H. Mai, N.H. Phu, H.D. Nghia, L.V. Chuong, D.X. Sinh, V.A. Duong, P.T. Diep, J.I. 
Campbell, S. Baker, T.T. Hien, D.G. Lalloo, J.J. Farrar & J.N. Day, (2010) A prospective 
descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - 
high prevalence of Cryptococcus neoformans var grubii in the absence of underlying 
disease. BMC infectious diseases 10: 199. 
Chayakulkeeree, M., T.C. Sorrell, A.R. Siafakas, C.F. Wilson, N. Pantarat, K.J. Gerik, R. Boadle 
& J.T. Djordjevic, (2008) Role and mechanism of phosphatidylinositol-specific 
phospholipase C in survival and virulence of Cryptococcus neoformans. Molecular 
microbiology 69: 809-826. 
Chen, S.C., L.C. Wright, J.C. Golding & T.C. Sorrell, (2000) Purification and characterization of 
secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase 
from a virulent strain of the pathogenic fungus Cryptococcus neoformans. The 
Biochemical journal 347: 431-439. 
Chi, H., X. Yang, P.D. Kingsley, R.J. O'Keefe, J.E. Puzas, R.N. Rosier, S.B. Shears & P.R. 
Reynolds, (2000) Targeted deletion of Minpp1 provides new insight into the activity 
of multiple inositol polyphosphate phosphatase in vivo. Molecular and cellular 
biology 20: 6496-6507. 
76 
 
Collopy-Junior, I., F.F. Esteves, L. Nimrichter, M.L. Rodrigues, C.S. Alviano & J.R. Meyer-
Fernandes, (2006) An ectophosphatase activity in Cryptococcus neoformans. FEMS 
yeast research 6: 1010-1017. 
Djordjevic, J.T., (2010) Role of phospholipases in fungal fitness, pathogenicity, and drug 
development - lessons from Cryptococcus neoformans. Frontiers in microbiology 1: 
125. 
Djordjevic, J.T., M. Del Poeta, T.C. Sorrell, K.M. Turner & L.C. Wright, (2005) Secretion of 
cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol 
(GPI) anchor. The Biochemical journal 389: 803-812. 
Doering, T.L., (2009) How sweet it is! Cell wall biogenesis and polysaccharide capsule 
formation in Cryptococcus neoformans. Annual review of microbiology 63: 223-247. 
Falkow, S., (1988) Molecular Koch's postulates applied to microbial pathogenicity. Reviews 
of infectious diseases 10 Suppl 2: S274-276. 
Fan, W., P.R. Kraus, M.J. Boily & J. Heitman, (2005) Cryptococcus neoformans gene 
expression during murine macrophage infection. Eukaryotic cell 4: 1420-1433. 
Fernanado, P.H., G.J. Panagoda & L.P. Samaranayake, (1999) The relationship between the 
acid and alkaline phosphatase activity and the adherence of clinical isolates of 
Candida parapsilosis to human buccal epithelial cells. APMIS : acta pathologica, 
microbiologica, et immunologica Scandinavica 107: 1034-1042. 
Fleisig, H., A. El-Din El-Husseini & S.R. Vincent, (2004) Regulation of ErbB4 phosphorylation 
and cleavage by a novel histidine acid phosphatase. Neuroscience 127: 91-100. 
Fries, B.C., S.C. Lee, R. Kennan, W. Zhao, A. Casadevall & D.L. Goldman, (2005) Phenotypic 
switching of Cryptococcus neoformans can produce variants that elicit increased 
intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infection 
and immunity 73: 1779-1787. 
Fyfe, M., L. MacDougall, M. Romney, M. Starr, M. Pearce, S. Mak, S. Mithani & P. Kibsey, 
(2008) Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: 
emergence of a tropical fungus in a temperate environment. Canada communicable 
disease report = Releve des maladies transmissibles au Canada 34: 1-12. 
Garcia-Rodas, R., A. Casadevall, J.L. Rodriguez-Tudela, M. Cuenca-Estrella & O. Zaragoza, 
(2011) Cryptococcus neoformans capsular enlargement and cellular gigantism during 
Galleria mellonella infection. PloS one 6: e24485. 
Geunes-Boyer, S., T.N. Oliver, G. Janbon, J.K. Lodge, J. Heitman, J.R. Perfect & J.R. Wright, 
(2009) Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus 
neoformans by murine macrophages and enhances fungal survival. Infection and 
immunity 77: 2783-2794. 
Ghannoum, M.A., (2000) Potential role of phospholipases in virulence and fungal 
pathogenesis. Clinical microbiology reviews 13: 122-143, table of contents. 
Ghannoum, M.A. & L.B. Rice, (1999) Antifungal agents: mode of action, mechanisms of 
resistance, and correlation of these mechanisms with bacterial resistance. Clinical 
microbiology reviews 12: 501-517. 
Gomes, M.T., A.H. Lopes & J.R. Meyer-Fernandes, (2011) Possible roles of ectophosphatases 
in host-parasite interactions. Journal of parasitology research 2011: 479146. 
Guerrero, A. & B.C. Fries, (2008) Phenotypic switching in Cryptococcus neoformans 
contributes to virulence by changing the immunological host response. Infection and 
immunity 76: 4322-4331. 
77 
 
Hartel, H., P. Dormann & C. Benning, (2000) DGD1-independent biosynthesis of 
extraplastidic galactolipids after phosphate deprivation in Arabidopsis. Proceedings 
of the National Academy of Sciences of the United States of America 97: 10649-
10654. 
Hasko, G. & P. Pacher, (2012) Regulation of macrophage function by adenosine. 
Arteriosclerosis, thrombosis, and vascular biology 32: 865-869. 
Hasko, G., P. Pacher, E.A. Deitch & E.S. Vizi, (2007) Shaping of monocyte and macrophage 
function by adenosine receptors. Pharmacology & therapeutics 113: 264-275. 
Hull, C.M. & J. Heitman, (2002) Genetics of Cryptococcus neoformans. Annual review of 
genetics 36: 557-615. 
Jain, N., A. Guerrero & B.C. Fries, (2006a) Phenotypic switching and its implications for the 
pathogenesis of Cryptococcus neoformans. FEMS yeast research 6: 480-488. 
Jain, N., L. Li, D.C. McFadden, U. Banarjee, X. Wang, E. Cook & B.C. Fries, (2006b) Phenotypic 
switching in a Cryptococcus neoformans variety gattii strain is associated with 
changes in virulence and promotes dissemination to the central nervous system. 
Infection and immunity 74: 896-903. 
Jarvis, J.N., A. Percival, S. Bauman, J. Pelfrey, G. Meintjes, G.N. Williams, N. Longley, T.S. 
Harrison & T.R. Kozel, (2011) Evaluation of a novel point-of-care cryptococcal antigen 
test on serum, plasma, and urine from patients with HIV-associated cryptococcal 
meningitis. Clinical infectious diseases : an official publication of the Infectious 
Diseases Society of America 53: 1019-1023. 
Kiffer-Moreira, T., A.A. de Sa Pinheiro, W.S. Alviano, F.M. Barbosa, T. Souto-Padron, L. 
Nimrichter, M.L. Rodrigues, C.S. Alviano & J.R. Meyer-Fernandes, (2007a) An 
ectophosphatase activity in Candida parapsilosis influences the interaction of fungi 
with epithelial cells. FEMS yeast research 7: 621-628. 
Kiffer-Moreira, T., A.A. Pinheiro, M.R. Pinto, F.F. Esteves, T. Souto-Padron, E. Barreto-Bergter 
& J.R. Meyer-Fernandes, (2007b) Mycelial forms of Pseudallescheria boydii present 
ectophosphatase activities. Archives of microbiology 188: 159-166. 
Klock, C., M. Cerski & L.Z. Goldani, (2009) Histopathological aspects of neurocryptococcosis 
in HIV-infected patients: autopsy report of 45 patients. International journal of 
surgical pathology 17: 444-448. 
Kneipp, L.F., A.S. Magalhaes, E.A. Abi-Chacra, L.O. Souza, C.S. Alviano, A.L. Santos & J.R. 
Meyer-Fernandes, (2012) Surface phosphatase in Rhinocladiella aquaspersa: 
biochemical properties and its involvement with adhesion. Medical mycology 50: 
570-578. 
Kneipp, L.F., V.F. Palmeira, A.A. Pinheiro, C.S. Alviano, S. Rozental, L.R. Travassos & J.R. 
Meyer-Fernandes, (2003) Phosphatase activity on the cell wall of Fonsecaea pedrosoi. 
Medical mycology 41: 469-477. 
Kneipp, L.F., M.L. Rodrigues, C. Holandino, F.F. Esteves, T. Souto-Padron, C.S. Alviano, L.R. 
Travassos & J.R. Meyer-Fernandes, (2004) Ectophosphatase activity in conidial forms 
of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal 
adhesion to mammalian cells. Microbiology 150: 3355-3362. 
Kraus, P.R., C.B. Nichols & J. Heitman, (2005) Calcium- and calcineurin-independent roles for 
calmodulin in Cryptococcus neoformans morphogenesis and high-temperature 
growth. Eukaryotic cell 4: 1079-1087. 
Kretschmer, M., E. Reiner, G. Hu, N. Tam, D.L. Oliveira, M. Caza, J.H. Yeon, J. Kim, C.J. 
Kastrup, W.H. Jung & J.W. Kronstad, (2014) Defects in phosphate acquisition and 
78 
 
storage influence virulence of Cryptococcus neoformans. Infection and immunity 82: 
2697-2712. 
Lenburg, M.E. & E.K. O'Shea, (1996) Signaling phosphate starvation. Trends in biochemical 
sciences 21: 383-387. 
Lev, S., B. Crossett, S.Y. Cha, D. Desmarini, C. Li, M. Chayakulkeeree, C.F. Wilson, P.R. 
Williamson, T.C. Sorrell & J.T. Djordjevic, (2014) Identification of Aph1, a Phosphate-
Regulated, Secreted, and Vacuolar Acid Phosphatase in Cryptococcus neoformans. 
mBio 5. 
Loftus, B.J., E. Fung, P. Roncaglia, D. Rowley, P. Amedeo, D. Bruno, J. Vamathevan, M. 
Miranda, I.J. Anderson, J.A. Fraser, J.E. Allen, I.E. Bosdet, M.R. Brent, R. Chiu, T.L. 
Doering, M.J. Donlin, C.A. D'Souza, D.S. Fox, V. Grinberg, J. Fu, M. Fukushima, B.J. 
Haas, J.C. Huang, G. Janbon, S.J. Jones, H.L. Koo, M.I. Krzywinski, J.K. Kwon-Chung, 
K.B. Lengeler, R. Maiti, M.A. Marra, R.E. Marra, C.A. Mathewson, T.G. Mitchell, M. 
Pertea, F.R. Riggs, S.L. Salzberg, J.E. Schein, A. Shvartsbeyn, H. Shin, M. Shumway, C.A. 
Specht, B.B. Suh, A. Tenney, T.R. Utterback, B.L. Wickes, J.R. Wortman, N.H. Wye, 
J.W. Kronstad, J.K. Lodge, J. Heitman, R.W. Davis, C.M. Fraser & R.W. Hyman, (2005) 
The genome of the basidiomycetous yeast and human pathogen Cryptococcus 
neoformans. Science 307: 1321-1324. 
Long, M., E. Betran, K. Thornton & W. Wang, (2003) The origin of new genes: glimpses from 
the young and old. Nature reviews. Genetics 4: 865-875. 
Lopez-Lara, I.M., J.L. Gao, M.J. Soto, A. Solares-Perez, B. Weissenmayer, C. Sohlenkamp, G.P. 
Verroios, J. Thomas-Oates & O. Geiger, (2005) Phosphorus-free membrane lipids of 
Sinorhizobium meliloti are not required for the symbiosis with alfalfa but contribute 
to increased cell yields under phosphorus-limiting conditions of growth. Molecular 
plant-microbe interactions : MPMI 18: 973-982. 
McFadden, D., O. Zaragoza & A. Casadevall, (2006) The capsular dynamics of Cryptococcus 
neoformans. Trends in microbiology 14: 497-505. 
Meyer-Fernandes, J.R., M.A. da Silva-Neto, S. Soares Mdos, E. Fernandes, A.E. Vercesi & 
M.M. de Oliveira, (1999) Ecto-phosphatase activities on the cell surface of the 
amastigote forms of Trypanosoma cruzi. Zeitschrift fur Naturforschung. C, Journal of 
biosciences 54: 977-984. 
Mitchell, T.G., Perfect J.R., (1995) Cryptococcosis in the Era of AIDS—100 Years after the 
Discovery of Cryptococcus neoforman. Clinical microbiology reviews 8: 515-548 
Murray, P.R., Rosenthal, K. S. & Pfaller, M. A., (2009) Medical Microbiology. Mosby/Elsevier, 
Philadelphia. 
Nakamura, Y., (2013) Phosphate starvation and membrane lipid remodeling in seed plants. 
Progress in lipid research 52: 43-50. 
Nichols, C.B., Z.H. Perfect & J.A. Alspaugh, (2007) A Ras1-Cdc24 signal transduction pathway 
mediates thermotolerance in the fungal pathogen Cryptococcus neoformans. 
Molecular microbiology 63: 1118-1130. 
Nicola, A.M., E.J. Robertson, P. Albuquerque, S. Derengowski Lda & A. Casadevall, (2011) 
Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo 
and is influenced by phagosomal pH. mBio 2. 
Oshima, Y., (1997) The phosphatase system in Saccharomyces cerevisiae. Genes & genetic 
systems 72: 323-334. 
79 
 
Park, B.J., K.A. Wannemuehler, B.J. Marston, N. Govender, P.G. Pappas & T.M. Chiller, (2009) 
Estimation of the current global burden of cryptococcal meningitis among persons 
living with HIV/AIDS. Aids 23: 525-530. 
Persson, B.L., J.O. Lagerstedt, J.R. Pratt, J. Pattison-Granberg, K. Lundh, S. Shokrollahzadeh & 
F. Lundh, (2003) Regulation of phosphate acquisition in Saccharomyces cerevisiae. 
Current genetics 43: 225-244. 
Portela, M.B., L.F. Kneipp, I.P. Ribeiro de Souza, C. Holandino, C.S. Alviano, J.R. Meyer-
Fernandes & R.M. de Araujo Soares, (2010) Ectophosphatase activity in Candida 
albicans influences fungal adhesion: study between HIV-positive and HIV-negative 
isolates. Oral diseases 16: 431-437. 
Pradel, E. & P.L. Boquet, (1991) Utilization of exogenous glucose-1-phosphate as a source of 
carbon or phosphate by Escherichia coli K12: respective roles of acid glucose-1-
phosphatase, hexose-phosphate permease, phosphoglucomutase and alkaline 
phosphatase. Research in microbiology 142: 37-45. 
Prescott, L.M., Harley, J. P. & Klein, D. A., (2005) Microbiology. McGraw-Hill, New York. 
Prince, V.E. & F.B. Pickett, (2002) Splitting pairs: the diverging fates of duplicated genes. 
Nature reviews. Genetics 3: 827-837. 
Pukkila-Worley, R., Q.D. Gerrald, P.R. Kraus, M.J. Boily, M.J. Davis, S.S. Giles, G.M. Cox, J. 
Heitman & J.A. Alspaugh, (2005) Transcriptional network of multiple capsule and 
melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. 
Eukaryotic cell 4: 190-201. 
Puri, R.V., P.V. Reddy & A.K. Tyagi, (2013) Secreted acid phosphatase (SapM) of 
Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation 
and growth of the pathogen in guinea pig tissues. PloS one 8: e70514. 
Remaley, A.T., D.B. Kuhns, R.E. Basford, R.H. Glew & S.S. Kaplan, (1984) Leishmanial 
phosphatase blocks neutrophil O-2 production. The Journal of biological chemistry 
259: 11173-11175. 
Rigden, D.J., (2008) The histidine phosphatase superfamily: structure and function. The 
Biochemical journal 409: 333-348. 
Saha, A.K., J.N. Dowling, A.W. Pasculle & R.H. Glew, (1988) Legionella micdadei phosphatase 
catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate in human 
neutrophils. Archives of biochemistry and biophysics 265: 94-104. 
Salas, S.D., J.E. Bennett, K.J. Kwon-Chung, J.R. Perfect & P.R. Williamson, (1996) Effect of the 
laccase gene CNLAC1, on virulence of Cryptococcus neoformans. The Journal of 
experimental medicine 184: 377-386. 
Shakarian, A.M., M.B. Joshi, E. Ghedin & D.M. Dwyer, (2002) Molecular dissection of the 
functional domains of a unique, tartrate-resistant, surface membrane acid 
phosphatase in the primitive human pathogen Leishmania donovani. The Journal of 
biological chemistry 277: 17994-18001. 
Shapiro, R.S., N. Robbins & L.E. Cowen, (2011) Regulatory circuitry governing fungal 
development, drug resistance, and disease. Microbiology and molecular biology 
reviews : MMBR 75: 213-267. 
Siafakas, A.R., T.C. Sorrell, L.C. Wright, C. Wilson, M. Larsen, R. Boadle, P.R. Williamson & J.T. 
Djordjevic, (2007) Cell wall-linked cryptococcal phospholipase B1 is a source of 
secreted enzyme and a determinant of cell wall integrity. The Journal of biological 
chemistry 282: 37508-37514. 
80 
 
Siafakas, A.R., L.C. Wright, T.C. Sorrell & J.T. Djordjevic, (2006) Lipid rafts in Cryptococcus 
neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn 
superoxide dismutase. Eukaryotic cell 5: 488-498. 
Slavin, M., J. Fastenau, I. Sukarom, P. Mavros, S. Crowley & W.C. Gerth, (2004) Burden of 
hospitalization of patients with Candida and Aspergillus infections in Australia. 
International journal of infectious diseases : IJID : official publication of the 
International Society for Infectious Diseases 8: 111-120. 
Sun, L.M., T.Y. Chen, W.J. Chen, M.J. Hsieh, J.W. Liu, C.C. Huang & C.J. Wang, (2002) 
Cryptococcus infection in a patient with nasopharyngeal carcinoma: imaging findings 
mimicking pulmonary metastases. The British journal of radiology 75: 275-278. 
Tanaka, M., Y. Kishi, Y. Takanezawa, Y. Kakehi, J. Aoki & H. Arai, (2004) Prostatic acid 
phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS letters 571: 
197-204. 
Toffaletti, D.L., T.H. Rude, S.A. Johnston, D.T. Durack & J.R. Perfect, (1993) Gene transfer in 
Cryptococcus neoformans by use of biolistic delivery of DNA. Journal of bacteriology 
175: 1405-1411. 
Tomar, P. & H. Sinha, (2014) Conservation of PHO pathway in ascomycetes and the role of 
Pho84. Journal of biosciences 39: 525-536. 
Vecchiarelli, A. & C. Monari, (2012) Capsular Material of Cryptococcus neoformans: 
Virulence and Much More. Mycopathologia. 
Vidotto, V., S. Ito-Kuwa, K. Nakamura, S. Aoki, M. Melhem, K. Fukushima & E. Bollo, (2006) 
Extracellular enzymatic activities in Cryptococcus neoformans strains isolated from 
AIDS patients in different countries. Revista iberoamericana de micologia 23: 216-
220. 
Voelz, K., S.A. Johnston, J.C. Rutherford & R.C. May, (2010) Automated analysis of 
cryptococcal macrophage parasitism using GFP-tagged cryptococci. PloS one 5: 
e15968. 
Waugh, M.S., C.B. Nichols, C.M. DeCesare, G.M. Cox, J. Heitman & J.A. Alspaugh, (2002) Ras1 
and Ras2 contribute shared and unique roles in physiology and virulence of 
Cryptococcus neoformans. Microbiology 148: 191-201. 
Williamson, P.R., (1994) Biochemical and molecular characterization of the diphenol oxidase 
of Cryptococcus neoformans: identification as a laccase. Journal of bacteriology 176: 
656-664. 
Wykoff, D.D. & E.K. O'Shea, (2001) Phosphate transport and sensing in Saccharomyces 
cerevisiae. Genetics 159: 1491-1499. 
Xander, P., A.F. Vigna, S. Feitosa Ldos, L. Pugliese, A.M. Bailao, C.M. Soares, R.A. Mortara, M. 
Mariano & J.D. Lopes, (2007) A surface 75-kDa protein with acid phosphatase activity 
recognized by monoclonal antibodies that inhibit Paracoccidioides brasiliensis 
growth. Microbes and infection / Institut Pasteur 9: 1484-1492. 
Zaragoza, O., M.L. Rodrigues, M. De Jesus, S. Frases, E. Dadachova & A. Casadevall, (2009) 
The capsule of the fungal pathogen Cryptococcus neoformans. Advances in applied 
microbiology 68: 133-216. 
 
 
